{ "entity_id": "B-000708", "folder": "National-Immunisation-Committee", "name": "National Immunisation Committee", "type": "Advisory Body", "jurisdiction": "Commonwealth", "portfolio": "Health, Disability and Ageing", "website": "https://www.health.gov.au/health-topics/immunisation/about-immunisation/immunisation-policy-and-governance#national-immunisation-committee", "data_status": "partial", "completeness": { "has_strategy_brief": true, "has_strategy_structured": true, "has_vision": false, "has_kpi_targets": true, "has_kpi_results": true, "has_strategy_overview": true, "has_legislation_text": true, "has_legislation_structured": false, "has_global_initiatives_text": false, "has_ideas": true, "has_artifacts": true, "n_ideas": 12, "n_legislation": 0, "n_artifacts": 12, "n_kpi_targets": 1, "n_kpi_results": 1, "n_outcomes": 1, "verified_own_data": true }, "strategy_profile": { "status": "needs_review", "confidence": "medium", "summary": "To improve the health of all Australians by reducing the prevalence of tobacco use and its associated health, social, environmental and economic costs, and the inequalities it causes", "official_site_url": "https://www.health.gov.au/health-topics/immunisation/about-immunisation/immunisation-policy-and-governance#national-immunisation-committee", "source_documents": [ { "type": "strategie", "title": "Standard for AI transparency statements", "url": "https://www.digital.gov.au/sites/default/files/documents/2024-08/Standard%20for%20AI%20transparency%20statements%20v1.1.pdf", "period": "2024", "confidence": "medium" }, { "type": "strategie", "title": "National Preventive Health Strategy 2021–2030 [PDF - 10 MB] - 95 pages", "url": "https://www.health.gov.au/sites/default/files/documents/2021/12/national-preventive-health-strategy-2021-2030_1.pdf", "period": "2021", "confidence": "medium" }, { "type": "strategie", "title": "National Preventive Health Strategy 2021–2030 [PDF - 920 KB] - 2 pages", "url": "https://www.health.gov.au/sites/default/files/documents/2021/12/national-preventive-health-strategy-2021-2030-national-preventive-health-strategy-2021-2030-summary.pdf", "period": "2021", "confidence": "medium" }, { "type": "strategie", "title": "National Men's Health Strategy 2020–2030 [PDF - 3 MB] - 42 pages", "url": "https://www.health.gov.au/sites/default/files/documents/2021/05/national-men-s-health-strategy-2020-2030_0.pdf", "period": "2021", "confidence": "medium" }, { "type": "strategie", "title": "National Women's Health Strategy 2020–2030 [PDF - 3 MB] - 59 pages", "url": "https://www.health.gov.au/sites/default/files/documents/2021/05/national-women-s-health-strategy-2020-2030_0.pdf", "period": "2021", "confidence": "medium" }, { "type": "strategie", "title": "National Action Plan for the Health of Children and Young People 2020–2030 [PDF - 2 MB] - 52 pages", "url": "https://www.health.gov.au/sites/default/files/documents/2021/04/national-action-plan-for-the-health-of-children-and-young-people-2020-2030-national-action-plan-for-the-health-of-children-and-young-people-2020-2030.pdf", "period": "2021", "confidence": "medium" }, { "type": "strategie", "title": "National Strategic Framework for Chronic Conditions [PDF - 2 MB]", "url": "https://www.health.gov.au/sites/default/files/2026-03/national-strategic-framework-for-chronic-conditions_0.pdf", "period": "2026", "confidence": "medium" }, { "type": "strategie", "title": "National Obesity Strategy 2022–2032 [PDF - 2 MB] - 87 pages", "url": "https://www.health.gov.au/sites/default/files/documents/2022/03/national-obesity-strategy-2022-2032_0.pdf", "period": "2022", "confidence": "medium" }, { "type": "strategie", "title": "National Tobacco Strategy 2023–2030 [PDF - 2 MB] - 46 pages", "url": "https://www.health.gov.au/sites/default/files/2023-05/national-tobacco-strategy-2023-2030.pdf", "period": "2023", "confidence": "medium" }, { "type": "strategie", "title": "National Alcohol Strategy 2019–2028 [PDF - 583 KB] - 44 pages", "url": "https://www.health.gov.au/sites/default/files/documents/2020/11/national-alcohol-strategy-2019-2028.pdf", "period": "2020", "confidence": "medium" }, { "type": "strategie", "title": "National Consumer Engagement Strategy for Health and Wellbeing [PDF - 3 MB]", "url": "https://www.health.gov.au/sites/default/files/2025-10/national-consumer-engagement-strategy-for-health-and-wellbeing.pdf", "period": "2025", "confidence": "medium" } ], "purpose": { "text": "To improve the health of all Australians by reducing the prevalence of tobacco use and its associated health, social, environmental and economic costs, and the inequalities it causes", "source_url": "https://www.health.gov.au/sites/default/files/2023-05/national-tobacco-strategy-2023-2030.pdf", "source_page": 3, "source_deep_url": "https://www.health.gov.au/sites/default/files/2023-05/national-tobacco-strategy-2023-2030.pdf#page=3" }, "vision": null, "strategic_priorities": [ { "title": "Eliminate all tobacco-related advertising, promotion and sponsorship", "description": "Eliminate all tobacco-related advertising, promotion and sponsorship", "source_url": "https://www.health.gov.au/sites/default/files/2023-05/national-tobacco-strategy-2023-2030.pdf", "source_page": 10, "source_deep_url": "https://www.health.gov.au/sites/default/files/2023-05/national-tobacco-strategy-2023-2030.pdf#page=10" }, { "title": "Further regulate the contents and product disclosures pertaining to tobacco products", "description": "Further regulate the contents and product disclosures pertaining to tobacco products", "source_url": "https://www.health.gov.au/sites/default/files/2023-05/national-tobacco-strategy-2023-2030.pdf", "source_page": 11, "source_deep_url": "https://www.health.gov.au/sites/default/files/2023-05/national-tobacco-strategy-2023-2030.pdf#page=11" }, { "title": "Strengthen regulation to reduce the supply, availability and accessibility of tobacco products", "description": "Strengthen regulation to reduce the supply, availability and accessibility of tobacco products", "source_url": "https://www.health.gov.au/sites/default/files/2023-05/national-tobacco-strategy-2023-2030.pdf", "source_page": 12, "source_deep_url": "https://www.health.gov.au/sites/default/files/2023-05/national-tobacco-strategy-2023-2030.pdf#page=12" }, { "title": "Strengthen regulations on e-cigarettes and novel and emerging products", "description": "Strengthen regulations on e-cigarettes and novel and emerging products", "source_url": "https://www.health.gov.au/sites/default/files/2023-05/national-tobacco-strategy-2023-2030.pdf", "source_page": 13, "source_deep_url": "https://www.health.gov.au/sites/default/files/2023-05/national-tobacco-strategy-2023-2030.pdf#page=13" }, { "title": "Eliminate exceptions to smoke-free workplaces, public places and other settings", "description": "Eliminate exceptions to smoke-free workplaces, public places and other settings", "source_url": "https://www.health.gov.au/sites/default/files/2023-05/national-tobacco-strategy-2023-2030.pdf", "source_page": 14, "source_deep_url": "https://www.health.gov.au/sites/default/files/2023-05/national-tobacco-strategy-2023-2030.pdf#page=14" }, { "title": "Provide greater access to evidence-based cessation services to support people to quit the use of tobacco, e-cigarettes a", "description": "Provide greater access to evidence-based cessation services to support people to quit the use of tobacco, e-cigarettes and novel and emerging products", "source_url": "https://www.health.gov.au/sites/default/files/2023-05/national-tobacco-strategy-2023-2030.pdf", "source_page": 15, "source_deep_url": "https://www.health.gov.au/sites/default/files/2023-05/national-tobacco-strategy-2023-2030.pdf#page=15" }, { "title": "Develop, implement and fund evidence-based integrated public health campaigns and other communication tools to motivate ", "description": "Develop, implement and fund evidence-based integrated public health campaigns and other communication tools to motivate people who use tobacco to quit and recent quitters to continue smoking abstinence; discourage uptake of tobacco use; and reshape social norms about the tobacco industry and tobacco use", "source_url": "https://www.health.gov.au/sites/default/files/2023-05/national-tobacco-strategy-2023-2030.pdf", "source_page": 16, "source_deep_url": "https://www.health.gov.au/sites/default/files/2023-05/national-tobacco-strategy-2023-2030.pdf#page=16" }, { "title": "Continue to reduce the affordability of tobacco products", "description": "Continue to reduce the affordability of tobacco products", "source_url": "https://www.health.gov.au/sites/default/files/2023-05/national-tobacco-strategy-2023-2030.pdf", "source_page": 17, "source_deep_url": "https://www.health.gov.au/sites/default/files/2023-05/national-tobacco-strategy-2023-2030.pdf#page=17" }, { "title": "Strengthen and expand efforts and partnerships to prevent and reduce tobacco use among First Nations people", "description": "Strengthen and expand efforts and partnerships to prevent and reduce tobacco use among First Nations people", "source_url": "https://www.health.gov.au/sites/default/files/2023-05/national-tobacco-strategy-2023-2030.pdf", "source_page": 19, "source_deep_url": "https://www.health.gov.au/sites/default/files/2023-05/national-tobacco-strategy-2023-2030.pdf#page=19" }, { "title": "Strengthen efforts to prevent and reduce tobacco use among populations at a higher risk of harm from tobacco use and pop", "description": "Strengthen efforts to prevent and reduce tobacco use among populations at a higher risk of harm from tobacco use and populations with a high prevalence of tobacco use", "source_url": "https://www.health.gov.au/sites/default/files/2023-05/national-tobacco-strategy-2023-2030.pdf", "source_page": 20, "source_deep_url": "https://www.health.gov.au/sites/default/files/2023-05/national-tobacco-strategy-2023-2030.pdf#page=20" } ], "values": [], "outcomes": [ { "name": "Outcome 1: Tobacco use", "description": "Tobacco use causes more deaths than any other behavioural risk factor in Australia, contributing 8.6% of the total disease burden in 2018. Up to two-thirds of deaths in tobacco smokers can be attributed to smoking, and long-term smokers die an average of 10 years earlier than non-smokers.", "activities": [ "Continue to reduce the affordability of tobacco products", "Strengthen and expand efforts and partnerships to prevent and reduce tobacco use among First Nations people", "Strengthen efforts to prevent and reduce tobacco use among populations at a higher risk of harm from tobacco use and populations with a high prevalence of tobacco use" ], "source_url": "https://www.health.gov.au/sites/default/files/2023-05/national-tobacco-strategy-2023-2030.pdf", "source_page": 5, "source_deep_url": "https://www.health.gov.au/sites/default/files/2023-05/national-tobacco-strategy-2023-2030.pdf#page=5" } ], "performance_measures": [ { "code": "CCE01", "measure": "Prevalence of daily smoking among adults", "target": "10% reduction from 2017-18 levels", "latest_result": "12.7% (reduction from 14.7% in 2017-18)", "status": "Partially achieved", "target_source_url": "https://www.health.gov.au/sites/default/files/2023-05/national-tobacco-strategy-2023-2030.pdf", "target_source_page": 7, "result_source_url": "", "result_source_page": 7 } ], "document_alignment_terms": { "must_support": [ "To improve the health of all Australians by reducing the prevalence of tobacco use and its associated health, social, environmental and economic costs, and the inequalities it caus", "Eliminate all tobacco-related advertising, promotion and sponsorship", "Further regulate the contents and product disclosures pertaining to tobacco products", "Strengthen regulation to reduce the supply, availability and accessibility of tobacco products", "Strengthen regulations on e-cigarettes and novel and emerging products", "Eliminate exceptions to smoke-free workplaces, public places and other settings", "Provide greater access to evidence-based cessation services to support people to quit the use of tobacco, e-cigarettes and novel and emerging products", "Develop, implement and fund evidence-based integrated public health campaigns and other communication tools to motivate people who use tobacco to quit and recent quitters to continue smoking abstinence; discourage uptake of tobacco use; and reshape social norms about the tobacco industry and tobacco use", "Continue to reduce the affordability of tobacco products" ], "watch_terms": [ "Prevalence of daily smoking among adults" ], "avoid_claiming_without_evidence": [] }, "review_note": "Structured strategy exists but is incomplete." }, "strategy_brief_md": "# National Immunisation Committee — Strategy Brief\n\n**Reporting period**: 2024-25\n**Corporate plan in force**: 2025-26\n**Corporate Plan**: [2025-26](https://www.health.gov.au/sites/default/files/2023-05/national-tobacco-strategy-2023-2030.pdf)\n\n## Our purpose / purposes\n\n> To improve the health of all Australians by reducing the prevalence of tobacco use and its associated health, social, environmental and economic costs, and the inequalities it causes [[CP p.3](https://www.health.gov.au/sites/default/files/2023-05/national-tobacco-strategy-2023-2030.pdf#page=3)]\n\n## How we deliver\n\n> This Strategy builds on the success of previous national tobacco strategies and strengthens population-wide approaches that have been successful in reducing the prevalence of tobacco use over the past 4 decades. [[CP p.4](https://www.health.gov.au/sites/default/files/2023-05/national-tobacco-strategy-2023-2030.pdf#page=4)]\n\n## Government priorities for this department\n\n- Eliminate all tobacco-related advertising, promotion and sponsorship [[CP p.10](https://www.health.gov.au/sites/default/files/2023-05/national-tobacco-strategy-2023-2030.pdf#page=10)]\n- Further regulate the contents and product disclosures pertaining to tobacco products [[CP p.11](https://www.health.gov.au/sites/default/files/2023-05/national-tobacco-strategy-2023-2030.pdf#page=11)]\n- Strengthen regulation to reduce the supply, availability and accessibility of tobacco products [[CP p.12](https://www.health.gov.au/sites/default/files/2023-05/national-tobacco-strategy-2023-2030.pdf#page=12)]\n- Strengthen regulations on e-cigarettes and novel and emerging products [[CP p.13](https://www.health.gov.au/sites/default/files/2023-05/national-tobacco-strategy-2023-2030.pdf#page=13)]\n- Eliminate exceptions to smoke-free workplaces, public places and other settings [[CP p.14](https://www.health.gov.au/sites/default/files/2023-05/national-tobacco-strategy-2023-2030.pdf#page=14)]\n- Provide greater access to evidence-based cessation services to support people to quit the use of tobacco, e-cigarettes and novel and emerging products [[CP p.15](https://www.health.gov.au/sites/default/files/2023-05/national-tobacco-strategy-2023-2030.pdf#page=15)]\n- Develop, implement and fund evidence-based integrated public health campaigns and other communication tools to motivate people who use tobacco to quit and recent quitters to continue smoking abstinence; discourage uptake of tobacco use; and reshape social norms about the tobacco industry and tobacco use [[CP p.16](https://www.health.gov.au/sites/default/files/2023-05/national-tobacco-strategy-2023-2030.pdf#page=16)]\n- Continue to reduce the affordability of tobacco products [[CP p.17](https://www.health.gov.au/sites/default/files/2023-05/national-tobacco-strategy-2023-2030.pdf#page=17)]\n- Strengthen and expand efforts and partnerships to prevent and reduce tobacco use among First Nations people [[CP p.19](https://www.health.gov.au/sites/default/files/2023-05/national-tobacco-strategy-2023-2030.pdf#page=19)]\n- Strengthen efforts to prevent and reduce tobacco use among populations at a higher risk of harm from tobacco use and populations with a high prevalence of tobacco use [[CP p.20](https://www.health.gov.au/sites/default/files/2023-05/national-tobacco-strategy-2023-2030.pdf#page=20)]\n\n## Outcomes\n\n### Outcome 1: Tobacco use\nTobacco use causes more deaths than any other behavioural risk factor in Australia, contributing 8.6% of the total disease burden in 2018. Up to two-thirds of deaths in tobacco smokers can be attributed to smoking, and long-term smokers die an average of 10 years earlier than non-smokers. [[CP p.5](https://www.health.gov.au/sites/default/files/2023-05/national-tobacco-strategy-2023-2030.pdf#page=5)]\n\n**Key activities:**\n- Continue to reduce the affordability of tobacco products\n- Strengthen and expand efforts and partnerships to prevent and reduce tobacco use among First Nations people\n- Strengthen efforts to prevent and reduce tobacco use among populations at a higher risk of harm from tobacco use and populations with a high prevalence of tobacco use\n\n## What they will measure themselves on this year (targets from 2025-26 corporate plan)\n\n| Code | Measure | Target | Source |\n|---|---|---|---|\n| CCE01 | Prevalence of daily smoking among adults | 10% reduction from 2017-18 levels | [CP p.7](https://www.health.gov.au/sites/default/files/2023-05/national-tobacco-strategy-2023-2030.pdf#page=7) |\n\n## How they performed last year (results from 2024-25 annual report)\n\n| Code | Measure | Result | Status | Source |\n|---|---|---|---|---|\n| CCE01 | Prevalence of daily smoking among adults | 12.7% (reduction from 14.7% in 2017-18) | Partially achieved | AR p.7 |", "strategy_overview_evidence_md": null, "internal_strategy_evidence_md": "# National Immunisation Committee - Strategy, Performance, and Operating Profile\n\n**Generated at**: 2026-05-09T22:38:52.053158+00:00\n**Entity ID**: B-000708\n**Entity type**: Advisory Body\n**Jurisdiction**: Commonwealth\n**Portfolio**: Health, Disability and Ageing\n**Website**: https://www.health.gov.au/health-topics/immunisation/about-immunisation/immunisation-policy-and-governance#national-immunisation-committee\n\n> Draft generated from scraped source material. Treat this as an evidence pack for editorial review, not a final judgement.\n\n## Source Coverage\n\n| Source type | Count |\n|---|---:|\n| other-pdfs | 1 |\n| pages | 28 |\n| strategies | 11 |\n\n## Executive Readout\n\n### Purpose\n\n- [Page 71]\nStrategy implementation\nThe objectives, strategies and enablers of this\nStrategy create a pathway towards healthy living\nElements of success to drive cross-\nand achieving healthy weight for all Australians.\nsector collaboration and whole of\nThe Strategy also provides examples of evidence-\ngovernment actions include:\ninformed actions, including universal and targeted\nmeasures, for the Australian Government and\n• structures and systems\nstate and territory governments to consider.\nsupportive of multi-sectoral action\nThe Australian, state and territory governments\n• clear vision and leadership\nwill:\n• political will and an environment\n1. build on jurisdictional level obesity\nsupportive of problem solving and\nprevention and treatment policies\nand actions already in place or under acting on opportunities at all levels\ndevelopment, including identifying priority\n• strong partnerships\n Source: `strategies/national-obesity-strategy-2022-2032_0.pdf (https://www.health.gov.au/sites/default/files/documents/2022/03/national-obesity-strategy-2022-2032_0.pdf)`\n- Fill gaps in research, ensuring there • Utilise existing health promotion, public health research and\nare up-to-date figures for prevalence evaluation evidence to drive future actions.\nand measures for underreported\nconditions, such as chronic pain\n• Prioritise the development of screening and early detection\nSupport research into low survival tools.\ngynaecological cancers, such as • Develop a standardised clinical registry to track treatment\novarian cancer outcomes.\n• Improve access to clinical trials.\n• Consider implications and hormonal influence for treatment\nSupport targeted research into sex- and secondary prevention.\nand gender differences in profiling for • Support research to understand why breastfeeding is a\nchronic conditions modifiable risk factor for a range of cancers and chronic\nconditions.\n• Support research to understand comorbidities and linkages\n Source: `strategies/national-women-s-health-strategy-2020-2030_0.pdf (https://www.health.gov.au/sites/default/files/documents/2021/05/national-women-s-health-strategy-2020-2030_0.pdf)`\n- These\npoorer health outcomes extend across many key areas including life expectancy and mortality, incidences of\nmental illness and chronic conditions, health risk factors, such as smoking, alcohol, physical inactivity and\nunhealthy eating habits, sexual health, child and maternal health; and potentially avoidable deaths and\nhospitalisations.68\nThe Action Plan aligns with the National Aboriginal and Torres Strait Islander Heath and Implementation\nPlans 2013-2023, the National Framework for Health Services for Aboriginal and Torres Strait Islander\nChildren and Families 2016 and the National Cultural Respect Framework for Aboriginal and Torres Strait\nIslander Health 2016-2026.\n Source: `strategies/national-action-plan-for-the-health-of-children-and-young-people-2020-2030-natio.pdf (https://www.health.gov.au/sites/default/files/documents/2021/04/national-action-plan-for-the-health-of-children-and-young-people-2020-2030-national-action-plan-for-the-health-of-children-and-young-people-2020-2030.pdf)`\n- [pages 15,16,17,18,19]\nes such as: loss\nof a partner; major illness and in many cases illnesses; retirement; loss of purpose; financial distress; and social\nisolation\n• Prostate cancer is the second most commonly diagnosed cancer in males, accounting for one-quarter of cancer\nOlder men diagnoses, with incidence increasing with age13\n• From 65 to 74 years of age, coronary heart disease, lung cancer and chronic obstructive pulmonary disease\n(COPD) are the leading causes of burden6\n• After the age of 75, coronary heart disease, dementia and falls are the leading causes of total burden of disease6\n• Males aged 85 years and over have the highest rates of suicide across Australia, although these suicides account\nfor only 3% of all male deaths from intentional self-harm14\nNational Men’s Health Strategy 2020-2030 | 15\n|\n Source: `strategies/national-men-s-health-strategy-2020-2030_0.pdf (https://www.health.gov.au/sites/default/files/documents/2021/05/national-men-s-health-strategy-2020-2030_0.pdf)`\n\n### Role and Functions\n\n- Table 7 - The effect of commercial determinants on health\nCommercial element Protective Adverse\nMarketing and Social marketing promotes public Promotion of unhealthy products\nadvertising146-150 health and health promotion Enhances desirability and acceptability\nmessaging of unhealthy products\nCorporate political The provision of goods and services Lobbying\nactivities147, 151 such as health facilities, schools or Political donations\nother collective goods, especially in Barrier to public health policy\npolitical environments where these Shapes the social environment\ngoods are under-provided\nCorporate social Add meaningful benefit to society Enhances public perception and credibility\nresponsibility strategies by addressing a need of organisations who don’t have health\n147, 152 at the heart of their products or services\n Source: `strategies/national-preventive-health-strategy-2021-2030_1.pdf (https://www.health.gov.au/sites/default/files/documents/2021/12/national-preventive-health-strategy-2021-2030_1.pdf)`\n- [pages 19,20,21,22]\nr collective goods, especially in Barrier to public health policy\npolitical environments where these Shapes the social environment\ngoods are under-provided\nCorporate social Add meaningful benefit to society Enhances public perception and credibility\nresponsibility strategies by addressing a need of organisations who don’t have health\n147, 152 at the heart of their products or services\nSupply chains147, 153 Development of health-enhancing Resistance of inclusion of features\nproducts that enhance health due to cost\nDevelopment of products that are\ndetrimental to health\nThe commercial sector could play a pivotal role in positively shaping the health outcomes of\nAustralians by aligning their strategies to the health and wellbeing goals of society153, 154.\n Source: `strategies/national-preventive-health-strategy-2021-2030_1.pdf (https://www.health.gov.au/sites/default/files/documents/2021/12/national-preventive-health-strategy-2021-2030_1.pdf)`\n- The\nStrategy also reiterates Australia’s commitment to the World Health Organization (WHO) Global\nAction Plan for the Prevention of and Control of Non-Communicable Diseases 2013–2020, which\nincludes a voluntary target of a reduction in harmful alcohol consumption of 10% by 2025.1\nThe Strategy also reflects Australia’s support for WHO’s Global Strategy to Reduce Harmful Use\nof Alcohol2 (including strong alignment between the overarching aim, goals and priority areas of\nthis Strategy with the priorities and areas of action of the Global Strategy) and the United Nations\n2030 Agenda for Sustainable Development Goals.3\nImplementation of the Strategy, including decisions of funding, legislation and programs, is the\nresponsibility of jurisdictions.\n Source: `strategies/national-alcohol-strategy-2019-2028.pdf (https://www.health.gov.au/sites/default/files/documents/2020/11/national-alcohol-strategy-2019-2028.pdf)`\n- [pages 26,27,28]\natest risk of ill\nand action health and premature mortality\n• Demonstrate accountability for an equity-driven approach in the monitoring and\nevaluation of this strategy\n• Focus on prevention first and foremost – from primary prevention (keeping people\nhealthy) through to early diagnosis and intervention\n• Take a life-course approach to prevention, adapting information and activities to\nFocus on prevention men and boys at different life stages\n• Recognise that prevention goes beyond individual responsibility to the creation of\nhealthy environments and communities\n• Highlight the significance of gender as a key determinant of men’s health and\nAcknowledge the influence of gender on wellbeing\nhealth\n• Address gender inequality issues faced by men\nNational Men’s Health Strategy 2020-2030 | 26\n|\n Source: `strategies/national-men-s-health-strategy-2020-2030_0.pdf (https://www.health.gov.au/sites/default/files/documents/2021/05/national-men-s-health-strategy-2020-2030_0.pdf)`\n- 2–5 meet both the\n17%\nyear olds • Support women to breastfeed,\nAustralian Physical\n12% 5–12 Activity Guidelines and continue to breastfeed, by\nyear olds\nand recommended implementing the Australian National\n13–17\n2%\nyear olds screen time limits\nBreastfeeding Strategy: 2019 and\nFigure 9: The unhealthy food and drink intake of children Beyond. 🔍 🖹 🧍\nand physical activity levels of children and young\n• Support parents, carers and families\nadults.25,27\nto give their infants, children and\nadolescents healthy food and\nStarting early can empower parents and families\ndrinks (for example, appropriate\nto be role models for healthy behaviours and help\nnutrition when introducing solids,\nchildren enjoy healthy foods and physical activity,\nresponsive feeding, food portion\nwhich develops positive lifelong habits.123 This\nsize), encourage movement (for\ncan equip young people with the healthy living\n Source: `strategies/national-obesity-strategy-2022-2032_0.pdf (https://www.health.gov.au/sites/default/files/documents/2022/03/national-obesity-strategy-2022-2032_0.pdf)`\n- [pages 52,53,54]\nhild’s second birthday levels through role modelling and\ninfluences the likelihood of obesity in infancy, co-participation (in active recreation,\nchildhood, and later in life.125,126 Breastfeeding is active transport, active living) and\nalso a factor with longer periods of breastfeeding restricting screen time. 🧍\nassociated with a lower risk of childhood\noverweight and obesity.107,108 Most mothers in\nThe example actions focus on critical life stages\nAustralia initiate breastfeeding (96%), but these\n(pre-conception, pregnancy, new parenthood,\nrates drop off as babies grow, with only 29% of\nearly years).\n Source: `strategies/national-obesity-strategy-2022-2032_0.pdf (https://www.health.gov.au/sites/default/files/documents/2022/03/national-obesity-strategy-2022-2032_0.pdf)`\n\n### Strategic Priorities\n\n- [Page 33]\nContinue promoting and  Embed strategic priority areas from the National Strategic Framework for\nrefining preventive Chronic Conditions, 2017 relating to health promotion and risk\nhealth strategies and prevention181\ninterventions addressing  Promote awareness and understanding of food and drink labelling,\nsleep, nutrition, physical\nnutrition and activity guidelines with parents, young people and children\nactivity, and overweight\n Develop approaches to increase access to and provision of fresh fruit and\nand obesity\nvegetables to remote communities and among populations experiencing\ndisadvantage\n Support and evaluate school-based programs relating to nutrition and\nphysical activity\n Continue to investigate and assess options for labelling, promotion,\nadvertising and accessibility of food and drink, drawing on evidence-\nbased models in Australia and internationally\n Source: `strategies/national-action-plan-for-the-health-of-children-and-young-people-2020-2030-natio.pdf (https://www.health.gov.au/sites/default/files/documents/2021/04/national-action-plan-for-the-health-of-children-and-young-people-2020-2030-national-action-plan-for-the-health-of-children-and-young-people-2020-2030.pdf)`\n- [Page 4]\nTHE NATIONAL ALCOHOL\nSTRATEGY 2019–2028 AT A GLANCE\nAim\nTo prevent and minimise alcohol-related harms among individuals, families and communities by:\n• identifying agreed national priority areas of focus and policy options;\n• promoting and facilitating collaboration, partnership and commitment from the\ngovernment and non-government sectors; and,\n• targeting a 10% reduction in harmful alcohol consumption:\n- alcohol consumption at levels that puts individuals at risk of injury from a single\noccasion of drinking, at least monthly; and\n- alcohol consumption at levels that puts individuals at risk of disease or injury\nover a lifetime.\ni m\np r o v e c o m m t o t u a r n g i e c t a g t r i o o u n p s P r H o e a m lt\ni\nh o\nm\ni t e\na\ni r n\np n\nC g\nr d\no\no o\nm\nf v u a e\nm\nC\nn\nP\nl d c\ne\nn\na\ne\no e\ni\nn\nw\nt\no\nh r\ni\nt\ne\np\na s\nr\no\ns\nt r\ne\nl\nl a\ne\ne\nd\nh n n a d e r i s m\na\nn s\nn\ng s\n Source: `strategies/national-alcohol-strategy-2019-2028.pdf (https://www.health.gov.au/sites/default/files/documents/2020/11/national-alcohol-strategy-2019-2028.pdf)`\n- The\nStrategy also reiterates Australia’s commitment to the World Health Organization (WHO) Global\nAction Plan for the Prevention of and Control of Non-Communicable Diseases 2013–2020, which\nincludes a voluntary target of a reduction in harmful alcohol consumption of 10% by 2025.1\nThe Strategy also reflects Australia’s support for WHO’s Global Strategy to Reduce Harmful Use\nof Alcohol2 (including strong alignment between the overarching aim, goals and priority areas of\nthis Strategy with the priorities and areas of action of the Global Strategy) and the United Nations\n2030 Agenda for Sustainable Development Goals.3\nImplementation of the Strategy, including decisions of funding, legislation and programs, is the\nresponsibility of jurisdictions.\n Source: `strategies/national-alcohol-strategy-2019-2028.pdf (https://www.health.gov.au/sites/default/files/documents/2020/11/national-alcohol-strategy-2019-2028.pdf)`\n- LGBTIQ people are less likely than heterosexual people to be abstainers or ex-drinkers\n(14.4% compared to 21.3%); are more likely to be lifetime risk drinkers (25.8% compared to\n17.2%); and, more likely to consume 11 or more standard drinks on a monthly and yearly basis\n(12.6% compared to 6.9%, and 27.8% compared to 15.3%).32\nPeople from culturally and linguistically diverse (CALD) backgrounds\nWhile risky alcohol consumption is lower in non-English speaking populations (5.4%) than\nEnglish-speaking populations (18.7%),33 people from CALD backgrounds with alcohol use\nproblems are a priority population because of the barriers they may face to receiving appropriate\nhelp and support.\n Source: `strategies/national-alcohol-strategy-2019-2028.pdf (https://www.health.gov.au/sites/default/files/documents/2020/11/national-alcohol-strategy-2019-2028.pdf)`\n- [pages 13,14,15,16,17]\nn a monthly and yearly basis\n(12.6% compared to 6.9%, and 27.8% compared to 15.3%).32\nPeople from culturally and linguistically diverse (CALD) backgrounds\nWhile risky alcohol consumption is lower in non-English speaking populations (5.4%) than\nEnglish-speaking populations (18.7%),33 people from CALD backgrounds with alcohol use\nproblems are a priority population because of the barriers they may face to receiving appropriate\nhelp and support.\n Source: `strategies/national-alcohol-strategy-2019-2028.pdf (https://www.health.gov.au/sites/default/files/documents/2020/11/national-alcohol-strategy-2019-2028.pdf)`\n- [Page 17]\nPriority Group Select Health and Wellbeing Indicators\n Children and young people living with disability are more likely to be deprived across multiple\nChildren and young\nwellbeing domains, most commonly health, education and participation.50\npeople living with\n Approximately 85% of children and young people with a disability attend mainstream schools,\ndisability and chronic\nhowever more than 75% of school principals report not having enough resources to meet the\nconditions\nneeds of students with a disability.51\n 1 in 8 Australian adults experienced physical and/or sexual abuse before the age of 15.52\n In 2016–2017 there were 67,968 substantiations of child abuse and neglect, a 27% increase\nChildren and young\nsince 2012–2013.\n Source: `strategies/national-action-plan-for-the-health-of-children-and-young-people-2020-2030-natio.pdf (https://www.health.gov.au/sites/default/files/documents/2021/04/national-action-plan-for-the-health-of-children-and-young-people-2020-2030-national-action-plan-for-the-health-of-children-and-young-people-2020-2030.pdf)`\n- Elsewhere, a number of preventive health frameworks provide guidance and priority actions for specific\napproaches, including the National Immunisation Strategy for Australia 2019-2024, the National Asthma\nStrategy 2018, the Australian National Diabetes Strategy 2016-2020, Australia’s National Oral Health Plan\n2015-2024, and the National Disability Strategy 2010-2020.\n Source: `strategies/national-action-plan-for-the-health-of-children-and-young-people-2020-2030-natio.pdf (https://www.health.gov.au/sites/default/files/documents/2021/04/national-action-plan-for-the-health-of-children-and-young-people-2020-2030-national-action-plan-for-the-health-of-children-and-young-people-2020-2030.pdf)`\n- [Page 18]\nTable 3: Health condition risks for priority population groups – evidence of risk higher than the general\npopulation 16\nAboriginal Males living Males with Males in\nMales from socio-\nand Torres in rural and a disability, Males from Members of Socially the\nHealth economically Male\nStrait remote including CALD back- the LGBTI+ isolated criminal\nConditions disadvantaged veterans\nIslanders areas of mental grounds community males justice\nbackgrounds\nmales Australia illness system\nCHD x x x x x\nType 2\nx x x x x\nDiabetes\nCOPD x x x\nLung cancer x x x x\nDementia x\nMental ill-\nx x x x x x x x x\nhealth\nSuicide x x x x x x x x x\nInjuries x x x\nProstate\nx x\ncancer\nHIV x x\nChlamydia x\nGonorrhoea x x\nSyphilis x\nHepatitis\nx x x\nB & C\nNational Men’s Health Strategy 2020-2030 | 18\n|\n Source: `strategies/national-men-s-health-strategy-2020-2030_0.pdf (https://www.health.gov.au/sites/default/files/documents/2021/05/national-men-s-health-strategy-2020-2030_0.pdf)`\n- Health equity Target: Australians in regional and • B y increasing the amount of healthy years of life for\npeople within these communities, their health will be\nis achieved remote areas will have at least an\non a level that is closer to other Australians by 2030.\nfor priority additional three years of life lived\npopulations in full health by 2030\nTarget: Aboriginal and Torres\nStrait Islander people have at least\nan additional three years of life\nlived in full health by 2030\nUnderpinned by: Investment in • T his means that over the next 10 years, more money\nInvestment preventive health will rise to be will be invested to keep Australians healthy and well.\nin prevention 5% of total health expenditure • Increasing investment to 5% will significantly increase\nis increased across Commonwealth, state and the amount of prevention activities that can implemented\n Source: `strategies/national-preventive-health-strategy-2021-2030-national-preventive-health-strateg.pdf (https://www.health.gov.au/sites/default/files/documents/2021/12/national-preventive-health-strategy-2021-2030-national-preventive-health-strategy-2021-2030-summary.pdf)`\n- 8\nengagement 40\nVision 9\nInformation and health literacy 41\nAims 9\nResearch and evaluation 42\nPrinciples 10\nMonitoring and Surveillance 43\nPreparedness 45\nn Australia’s report card 11\nThe immediate priorities 47\nn Knowing the causes 13\nSocial 14\nEnvironmental 15\nStructural 16\nEconomic 16\nCultural 17\nBiomedical 18\nCommercial 19\nDigital 20\nPriority populations 21\nn Boosting Action 48\nReducing tobacco use 49\nImproving access to and the\nconsumption of a healthy diet 52\nIncreasing physical activity 55\nIncreasing cancer screening\nand prevention 58\nImproving immunisation coverage 61\nReducing alcohol and other drug harm 64\nPromoting and protecting\nmental health 68\nn Continuing Strong Foundations 71\nn Protecting our health 22 Monitoring Australia’s success 72\nWhat is prevention 22 Appendix A 73\nThe value of prevention 24 References 77\nNational Preventive Health Strategy 4\n Source: `strategies/national-preventive-health-strategy-2021-2030_1.pdf (https://www.health.gov.au/sites/default/files/documents/2021/12/national-preventive-health-strategy-2021-2030_1.pdf)`\n\n## KPIs, Targets, and Where They Are At\n\n- Health equity Target: Australians in regional and • B y increasing the amount of healthy years of life for\npeople within these communities, their health will be\nis achieved remote areas will have at least an\non a level that is closer to other Australians by 2030.\nfor priority additional three years of life lived\npopulations in full health by 2030\nTarget: Aboriginal and Torres\nStrait Islander people have at least\nan additional three years of life\nlived in full health by 2030\nUnderpinned by: Investment in • T his means that over the next 10 years, more money\nInvestment preventive health will rise to be will be invested to keep Australians healthy and well.\nin prevention 5% of total health expenditure • Increasing investment to 5% will significantly increase\nis increased across Commonwealth, state and the amount of prevention activities that can implemented\n Source: `strategies/national-preventive-health-strategy-2021-2030-national-preventive-health-strateg.pdf (https://www.health.gov.au/sites/default/files/documents/2021/12/national-preventive-health-strategy-2021-2030-national-preventive-health-strategy-2021-2030-summary.pdf)`\n- [pages 23,24,25,26,27]\numstances specific to the\nto participate in multiple target population group/s and\nengagement activities on the same identify any potential limitations\nor similar issues), as this can result in or constraints to engagement.\nengagement fatigue and be a barrier Mitigate these by fostering a safe\nto establishing sustained, trusted and inclusive environment for all\nrelationships with consumers and consumers.\ncommunities.\n• Investigate any other\nengagement activities that are\nunder way or have been\nundertaken in the community\npreviously to inform engagement\nplanning and avoid over-\nengagement with certain\ncommunities and population\ngroups.\n• Talk to community leaders, local\nstakeholders and consumers\ndirectly (where appropriate), to\ncanvass their views on the policy\nissue/s being considered.\n Source: `strategies/national-consumer-engagement-strategy-for-health-and-wellbeing.pdf (https://www.health.gov.au/sites/default/files/2025-10/national-consumer-engagement-strategy-for-health-and-wellbeing.pdf)`\n- The\nStrategy also reiterates Australia’s commitment to the World Health Organization (WHO) Global\nAction Plan for the Prevention of and Control of Non-Communicable Diseases 2013–2020, which\nincludes a voluntary target of a reduction in harmful alcohol consumption of 10% by 2025.1\nThe Strategy also reflects Australia’s support for WHO’s Global Strategy to Reduce Harmful Use\nof Alcohol2 (including strong alignment between the overarching aim, goals and priority areas of\nthis Strategy with the priorities and areas of action of the Global Strategy) and the United Nations\n2030 Agenda for Sustainable Development Goals.3\nImplementation of the Strategy, including decisions of funding, legislation and programs, is the\nresponsibility of jurisdictions.\n Source: `strategies/national-alcohol-strategy-2019-2028.pdf (https://www.health.gov.au/sites/default/files/documents/2020/11/national-alcohol-strategy-2019-2028.pdf)`\n- Target: The proportion of the • T his target means that the average young person will\nfirst 25 years lived in full health have more time where they are healthy and not affected\nwill increase by at least 2% by illness, disease or injury.\nby 2030 • T his will be achieved by increasing the prevention of\nrisk factors for chronic conditions, injuries and infectious\ndisease, as well as improving factors that protect and\npromote good health and wellbeing in childhood.\n Source: `strategies/national-preventive-health-strategy-2021-2030-national-preventive-health-strateg.pdf (https://www.health.gov.au/sites/default/files/documents/2021/12/national-preventive-health-strategy-2021-2030-national-preventive-health-strategy-2021-2030-summary.pdf)`\n- Target: The proportion of the first 25 years Target: Australians in the two lowest\nlived in full health will increase by at least SEIFA quintiles will have at least an\n2% by 2030 additional three years of life lived in\nTarget: The proportion of Aboriginal and full health by 2030\nTorres Strait Islander babies with a healthy Target: Australians in regional and remote\nbirthweight will increase to at least 91% areas will have at least an additional three\nby 2031 years of life lived in full health by 2030\nTarget: The proportion of the first 0-4 years Target: Aboriginal and Torres Strait Islander\nof life lived in full health will increase by at people will have at least an additional three\nleast 3.5% by 2030 years of life lived in full health by 2030\n2.\n Source: `strategies/national-preventive-health-strategy-2021-2030_1.pdf (https://www.health.gov.au/sites/default/files/documents/2021/12/national-preventive-health-strategy-2021-2030_1.pdf)`\n- CVD, stroke, diabetes,\ndementia, hypertensive diseases, kidney disease\nLow blood pressure is a risk factor for glaucoma\nBlood glucose levels4, 118, High blood glucose is a risk factor for CVD, retinopathy, kidney disease\n122, 123\nWeight range124-134 Overweight and obesity increases risk of diabetes, cancer, asthma, depression, and\nadverse outcomes during pregnancy such as preeclampsia and stillbirth\nUnderweight increases risk of CVD, stroke, heart attack, atrial fibrillation, infection,\nand adverse outcomes in pregnancy such as preterm delivery and low birthweight\nBlood cholesterol135 High blood cholesterol is associated with ischaemic heart disease\nGenetics, epigenetics and Increased risk of cancer due to genetic changes to telomeres\ntelomere biology136-144 Increased risk of alcohol dependence, diabetes, inflammatory bowel disease and\nAlzheimer’s disease due to genetic predisposition\n Source: `strategies/national-preventive-health-strategy-2021-2030_1.pdf (https://www.health.gov.au/sites/default/files/documents/2021/12/national-preventive-health-strategy-2021-2030_1.pdf)`\n- Consistent with the WHO the hospital sector $616.7 million21\ntarget for the Western Pacific Region, Australian\n• I n 2015, 15,781 years of healthy life were lost\ngovernments have committed to a target of 95% due to VPDs.\n Source: `strategies/national-preventive-health-strategy-2021-2030_1.pdf (https://www.health.gov.au/sites/default/files/documents/2021/12/national-preventive-health-strategy-2021-2030_1.pdf)`\n- One of the key\n• F unding for vaccine purchasing and services\nchallenges in improving immunisation coverage to support immunisation uptake has increased\nis to target immunisation to population groups from $10 million per year in the mid-1970s to\nwho are at increased risk from VPDs, including more than $460 million in 2017–18355\npregnant women and specific age cohorts357. • T he 2009 Adult Vaccination Survey estimated\nIn some cases, people working in areas with a that, for the population aged 65 years and\nhigh risk of transmission, such as health care, older, 74.6% were vaccinated against seasonal\naged care, or child care, are also at higher risk355. influenza and 54.4% against pneumococcal\nVaccination uptake among adults in Australia disease.\n Source: `strategies/national-preventive-health-strategy-2021-2030_1.pdf (https://www.health.gov.au/sites/default/files/documents/2021/12/national-preventive-health-strategy-2021-2030_1.pdf)`\n- In 2009, only 53.4% of at-risk is the target population for these vaccines,\n22.1% were not vaccinated for either disease358\nadults were vaccinated against influenza and\n30% of eligible older adults were vaccinated • I n 2009, only 11.3% of Australians aged 18 years\nagainst shingles358.\n Source: `strategies/national-preventive-health-strategy-2021-2030_1.pdf (https://www.health.gov.au/sites/default/files/documents/2021/12/national-preventive-health-strategy-2021-2030_1.pdf)`\n- However, alcohol\noccasion risk guidelines still remains an important public health issue that\n• I n 2019, people living in remote and very remote is associated with over 4,000 deaths, accounts\nareas were about 1.5 times as likely than those for 54% of drug-related hospitalisations, and has\nin major cities to exceed lifetime and single a significant impact on violence in Australian\noccasion risk guidelines (at least monthly)\ncommunities186, 341, 369, 370.\n• People aged 70 and over are the most likely to The consumption of alcohol during pregnancy\ndrink alcohol daily and the 50–59 age group are\ncan result in birth defects and behavioural and\nmost likely to exceed the lifetime risk guideline\nneurodevelopmental abnormalities known as\n• A higher proportion of people with a mental\nFetal Alcohol Spectrum Disorder which has\nhealth condition reported drinking at risky\n Source: `strategies/national-preventive-health-strategy-2021-2030_1.pdf (https://www.health.gov.au/sites/default/files/documents/2021/12/national-preventive-health-strategy-2021-2030_1.pdf)`\n- The proportion of the first Study, approx. every three n/a state of ill-health has a “disability weight”, which is the\nwill increase by at least 2%\n0-24 years lived in full health in 2018 was 92.6% years amount of suffering that it subtracts from the year of full\nby 2030\nAligns broadly with: health (which starts with a value of 1.0, and an experience\n• UN SGD Target 3.1 of disease or injury will reduce this by some proportional\n• UN SGD Target 3.2 amount).\n Source: `strategies/national-preventive-health-strategy-2021-2030_1.pdf (https://www.health.gov.au/sites/default/files/documents/2021/12/national-preventive-health-strategy-2021-2030_1.pdf)`\n- Relative reduction against baseline by at least 15%\n2011-12:\n2–5 years: 39% did not meet physical activity\nDefinition of physical inactivity for the target: An\nguideline\nabsence or sufficient level of physical activity required\n5–12 years: 74% did not meet guidelines\nto meet the current physical activity component of\n13–17 years: 92% did not meet guidelines\nABS National Health Survey the national recommendations.\n Source: `strategies/national-preventive-health-strategy-2021-2030_1.pdf (https://www.health.gov.au/sites/default/files/documents/2021/12/national-preventive-health-strategy-2021-2030_1.pdf)`\n- [pages 75,76]\nyear olds, and Department of Health), • WHO Immunisation Agenda 2030\nimmunisation a coverage rate of at least Health Plan\n97.3% of all five year olds were fully vaccinated Quarterly\ncoverage 95% for Aboriginal and Torres\nStrait Islander children aged\n5 years\nAligns broadly with:\n• Immunization Agenda 2030:\n80.2% coverage of females turning 15 years of age\nHPV immunisation rate National HPV Vaccination National Immunisation Proposed Impact Goal Indicators and\nin 2017\nincreased to at least 85% for Program Register (HPV Strategy for Australia 2019 Target 2.2\n75.9% coverage of males turning 15 years of age\nboth boys and girls by 2030 Register) to 2024 • WHO Global strategy to accelerate\nin 2017\nthe elimination of cervical cancer as\na public health problem\n75 National Preventive Health Strategy\n Source: `strategies/national-preventive-health-strategy-2021-2030_1.pdf (https://www.health.gov.au/sites/default/files/documents/2021/12/national-preventive-health-strategy-2021-2030_1.pdf)`\n- Reducing Aligns broadly with:\nalcohol and Less than 10% of pregnant In 2019, 29.7% of pregnant women aged 14 to 49 National Drug Strategy • WHO Global NCD targets for 2025 (2\nother drug women aged 14 to 49 are consumed alcohol before or after knowledge of Household Survey, every 2-3 n/a - Alcohol) Percentage point decrease to <10%\nharm consuming alcohol whilst pregnancy years • UN SDG Target 3.5\npregnant by 2030\nLess than 10% of young National Drug Strategy\nIn 2019, 30.2% of 14-17 year olds consumed alcohol\npeople (14-17 year olds) are Household Survey, every 2-3 n/a Percentage point decrease to <10%\nin the previous 12 months\nconsuming alcohol by 2030 years\nAt least a 15% decrease in the In 2019, 16.4% had used an illicit drug in the past National Drug Strategy Aligns broadly with:\n Source: `strategies/national-preventive-health-strategy-2021-2030_1.pdf (https://www.health.gov.au/sites/default/files/documents/2021/12/national-preventive-health-strategy-2021-2030_1.pdf)`\n\n## Key Metrics\n\n| Values found | Evidence | Source |\n|---|---|---|\n| $10.4 billion, $8.9 billion, 10.4 billion, 8.9 billion | Reducing the impact of these risk\nresponse’ chapter for further information). factors has the benefit of significantly reducing\nPreventable ill-health is putting enormous pressure on the health budget, as well as putting\npressure on the Australian healthcare budget. money back into the pockets of Australians and\nIn 2015–16, the cost of healthcare goods and increasing workplace participation, productivity\nservices was $10.4 billion for cardiovascu | `strategies/national-preventive-health-strategy-2021-2030_1.pdf (https://www.health.gov.au/sites/default/files/documents/2021/12/national-preventive-health-strategy-2021-2030_1.pdf)` |\n| $17.5 million, $200 million, 17.5 million, 200 million | Additional Commonwealth investment of $17.5 million through the Medical Research Future Fund was\nalso announced in the context of the 2018-19 Budget under the Maternal Health and First 2000\nDays/Women’s Health program.77\nIn August 2018, the Australian Government announced a further $200 million investment through the\nNHMRC and the Medical Research Future Fund, which also aligns with the priorities and actions outlined\nin the Strategy. | `strategies/national-women-s-health-strategy-2020-2030_0.pdf (https://www.health.gov.au/sites/default/files/documents/2021/05/national-women-s-health-strategy-2020-2030_0.pdf)` |\n| $13 billion, 13 billion | Furthermore, • In 2008, it was estimated that physical\nthere is some evidence that spending prolonged inactivity costs Australia more than $13 billion\nperiods of time in a sitting position leads to an each year in health care costs329\nincreased risk of cardiovascular disease and • In 2017-18, 11.5% of those aged 18–64 and 27%\npremature death317. | `strategies/national-preventive-health-strategy-2021-2030_1.pdf (https://www.health.gov.au/sites/default/files/documents/2021/12/national-preventive-health-strategy-2021-2030_1.pdf)` |\n| $10 million, $460 million, 10 million, 460 million | One of the key\n• F unding for vaccine purchasing and services\nchallenges in improving immunisation coverage to support immunisation uptake has increased\nis to target immunisation to population groups from $10 million per year in the mid-1970s to\nwho are at increased risk from VPDs, including more than $460 million in 2017–18355\npregnant women and specific age cohorts357. • T he 2009 Adult Vaccination Survey estimated\nIn some cases, people working | `strategies/national-preventive-health-strategy-2021-2030_1.pdf (https://www.health.gov.au/sites/default/files/documents/2021/12/national-preventive-health-strategy-2021-2030_1.pdf)` |\n| $1.89 billion, 1.89 billion | Findings from\ntobacco tax gap analysis by the Australian Taxation Office\nshow that the size of the illicit tobacco market in Australia\nin 2020–21 was estimated at $1.89 billion, approximately\n10.4% of the market.115 Measures to address the illicit\ntobacco trade are discussed in more detail under Priority\nArea 8. | `strategies/national-tobacco-strategy-2023-2030.pdf (https://www.health.gov.au/sites/default/files/2023-05/national-tobacco-strategy-2023-2030.pdf)` |\n| $5 billion, 5 billion | [Page 29]\nNational Strategic Framework for Chronic Conditions 2026–35 21\nAction Priority 2.2 Utilising digital technology and data\nThe Productivity Commission notes that enhancing the integration of digital technology\nwithin the healthcare sector could result in annual savings exceeding $5 billion. | `strategies/national-strategic-framework-for-chronic-conditions_0.pdf (https://www.health.gov.au/sites/default/files/2026-03/national-strategic-framework-for-chronic-conditions_0.pdf)` |\n| $1.9m | In the 2021-22 Budget it was announced that $1.9m would be put towards the initial implementation\nof the Strategy. | `strategies/national-preventive-health-strategy-2021-2030-national-preventive-health-strateg.pdf (https://www.health.gov.au/sites/default/files/documents/2021/12/national-preventive-health-strategy-2021-2030-national-preventive-health-strategy-2021-2030-summary.pdf)` |\n| $15.76 billion, $136.9 billion, $14.35 billion, 15.76 billion, 136.9 billion | In 2015-16, the social costs of opioid use\nspread of HIV, and the introduction of safe and tobacco use were estimated at $15.76 billion\ndriving measures such as compulsory seatbelt and $136.9 billion respectively186, and in 2010,\nuse in cars, random breath testing, and speed the estimated social cost of alcohol misuse was\nmonitoring interventions (see ‘Adapting our $14.35 billion186. | `strategies/national-preventive-health-strategy-2021-2030_1.pdf (https://www.health.gov.au/sites/default/files/documents/2021/12/national-preventive-health-strategy-2021-2030_1.pdf)` |\n| $2 billion, 2 billion | In the 30 years Preventive health action can also work to\nbetween 1970 and 2000, at least $2 billion in raise the health of priority populations to an\nnet benefits has been gained through health equitable level. | `strategies/national-preventive-health-strategy-2021-2030_1.pdf (https://www.health.gov.au/sites/default/files/documents/2021/12/national-preventive-health-strategy-2021-2030_1.pdf)` |\n| $4 billion, $6 billion, $2.3 billion, 4 billion, 6 billion, 2.3 billion | By introducing tax increases on in extra earnings, annual savings of $4 billion in\ntobacco (30% increase), alcohol (30% increase) welfare support payments could be made, and\nand unhealthy foods (10% increase), alongside 60,000 fewer people would need to be admitted\nmandatory salt limits on processed foods, it was to hospital annually resulting in savings of\nestimated that $6 billion of net savings could be $2.3 billion in hospital expenditure199. | `strategies/national-preventive-health-strategy-2021-2030_1.pdf (https://www.health.gov.au/sites/default/files/documents/2021/12/national-preventive-health-strategy-2021-2030_1.pdf)` |\n| $184.5 million, 5.3 million, 184.5 million | [pages 26,27,28]\nillion, and 5.3 million fewer\nneed to be utilised to direct preventive health Pharmaceutical Benefit Scheme scripts would\ninvestment in Australia to where it can be used need to be filled each year, resulting in annual\nmost efficiently and effectively, and to enable savings of $184.5 million each year199. | `strategies/national-preventive-health-strategy-2021-2030_1.pdf (https://www.health.gov.au/sites/default/files/documents/2021/12/national-preventive-health-strategy-2021-2030_1.pdf)` |\n| $27 million, 27 million, 3.1 million | [Page 60]\nKey Facts cont.\nthe context of behavioural science models to National Cervical Screening Program (NCSP)\nhelp segment audiences, identify trends and • I n 2015-16, the estimated health system cost for\ndevelop targeted strategies to drive participation. cervical cancer was over $27 million per year189\nIn the future, people can receive personalised • O ver 2018-19, secondary to the change in two\ncorrespondence, tailored to their circumstan | `strategies/national-preventive-health-strategy-2021-2030_1.pdf (https://www.health.gov.au/sites/default/files/documents/2021/12/national-preventive-health-strategy-2021-2030_1.pdf)` |\n| $9.9 billion, $43 billion, $70 billion, 9.9 billion, 43 billion, 70 billion | For\n14 and over had been diagnosed or treated for\npeople aged 10 to 24 years old, neuropsychiatric\na mental health condition in the previous 12\ndisorders, including anxiety and mood disorders,\nmonths382\nare the main cause of disability-adjusted life-\n• Australia spends over $9.9 billion each year on\nyears, accounting for 45% of the global burden\nmental health-related services377\nof disease388.\n• The cost of mental ill health and suicide to the\nSi | `strategies/national-preventive-health-strategy-2021-2030_1.pdf (https://www.health.gov.au/sites/default/files/documents/2021/12/national-preventive-health-strategy-2021-2030_1.pdf)` |\n| $87.7 billion, $678 , $11.8, $6.4, $5.4, 87.7 billion | These barriers society, the economy, and natural resources\ncan also limit a person’s options, or ability to be and ecosystems.12 If we don’t act, obesity may\nheard, when making health care decisions.8 cost an estimated $87.7 billion in just 10 years.13\nAnd to cover the costs of obesity, each Australian\npays an additional $678 in taxes each year.14\nWe must tackle stigma\nCost of obesity\nand weight-related $11.8b in Australia in 2018\ndiscrimination | `strategies/national-obesity-strategy-2022-2032_0.pdf (https://www.health.gov.au/sites/default/files/documents/2022/03/national-obesity-strategy-2022-2032_0.pdf)` |\n| $137 billion, 137 billion | The costs of tobacco use borne by the Australian and a range of novel and emerging products.47\ncommunity in 2015–16 were estimated to be $137 billion.33\nDuring the period of the 2012–2018 Strategy, rates\nTobacco use also remains the biggest contributor to\nof e-cigarette use among children and young people\nAustralia’s preventable health burden, contributing\nincreased markedly in numerous markets globally.48\n8.6% of the total burden of disease in A | `strategies/national-tobacco-strategy-2023-2030.pdf (https://www.health.gov.au/sites/default/files/2023-05/national-tobacco-strategy-2023-2030.pdf)` |\n| $73 million, 73 million | It is estimated that\nsmoking generally helps people manage their mental about one-third of cigarettes sold each year in Australia\nhealth condition, evidence suggests that smoking are littered.49 Littered cigarette butts contain plastic and\ncessation may help to improve rather than worsen chemical residues, including from pesticides, nicotine and\nmental health outcomes.40 heavy metals (leachates), which can contaminate soil and\nwater and can lead | `strategies/national-tobacco-strategy-2023-2030.pdf (https://www.health.gov.au/sites/default/files/2023-05/national-tobacco-strategy-2023-2030.pdf)` |\n| $73 million, 73 million | [pages 9,10,11]\nas people who had not\nbeen estimated at around $73 million per year.51\nbeen diagnosed or treated for mental health conditions\n(20% compared with 9.9%).41 People who smoke are more\nlikely to experience social isolation and loneliness, and\ncutting down smoking is associated with a reduction in\nsuicidality and depression. | `strategies/national-tobacco-strategy-2023-2030.pdf (https://www.health.gov.au/sites/default/files/2023-05/national-tobacco-strategy-2023-2030.pdf)` |\n| $616.7 million | Consistent with the WHO the hospital sector $616.7 million21\ntarget for the Western Pacific Region, Australian\n• I n 2015, 15,781 years of healthy life were lost\ngovernments have committed to a target of 95% due to VPDs. | `strategies/national-preventive-health-strategy-2021-2030_1.pdf (https://www.health.gov.au/sites/default/files/documents/2021/12/national-preventive-health-strategy-2021-2030_1.pdf)` |\n| $10 million, $460 million, 10 million, 460 million | One of the key\n• F unding for vaccine purchasing and services\nchallenges in improving immunisation coverage to support immunisation uptake has increased\nis to target immunisation to population groups from $10 million per year in the mid-1970s to\nwho are at increased risk from VPDs, including more than $460 million in 2017–18355\npregnant women and specific age cohorts357. • T he 2009 Adult Vaccination Survey estimated\nIn some cases, people working | `strategies/national-preventive-health-strategy-2021-2030_1.pdf (https://www.health.gov.au/sites/default/files/documents/2021/12/national-preventive-health-strategy-2021-2030_1.pdf)` |\n| 14 million | This creates unhealthy\nadults living with obesity.1 About 14 million environments and conditions that make it\nAustralians are living with overweight or harder for us to choose a healthy lifestyle.\nobesity2 - that’s 2 in every 3 adults, and 1\nin 4 children.2 Australia has committed to the World\nHealth Organization’s (WHO) global\nWithout further action we face a future target to halt the rise in overweight and\nwith more weight-related chronic disea | `strategies/national-obesity-strategy-2022-2032_0.pdf (https://www.health.gov.au/sites/default/files/documents/2022/03/national-obesity-strategy-2022-2032_0.pdf)` |\n\n## Key Achievements\n\n- [Page 3]\nContents\nINTRODUCTION 2 Priority Area 6: 21\nEliminate all tobacco-related advertising,\n1.1 Policy context 3\npromotion and sponsorship\n1.2 Progress and achievements under the\nNational Tobacco Strategy 2012–2018 4 Priority Area 7: 22\nFurther regulate the contents and product\n1.3 What challenges remain?\n Source: `strategies/national-tobacco-strategy-2023-2030.pdf (https://www.health.gov.au/sites/default/files/2023-05/national-tobacco-strategy-2023-2030.pdf)`\n- [pages 26,27,28]\natest risk of ill\nand action health and premature mortality\n• Demonstrate accountability for an equity-driven approach in the monitoring and\nevaluation of this strategy\n• Focus on prevention first and foremost – from primary prevention (keeping people\nhealthy) through to early diagnosis and intervention\n• Take a life-course approach to prevention, adapting information and activities to\nFocus on prevention men and boys at different life stages\n• Recognise that prevention goes beyond individual responsibility to the creation of\nhealthy environments and communities\n• Highlight the significance of gender as a key determinant of men’s health and\nAcknowledge the influence of gender on wellbeing\nhealth\n• Address gender inequality issues faced by men\nNational Men’s Health Strategy 2020-2030 | 26\n|\n Source: `strategies/national-men-s-health-strategy-2020-2030_0.pdf (https://www.health.gov.au/sites/default/files/documents/2021/05/national-men-s-health-strategy-2020-2030_0.pdf)`\n- [pages 33,34,35]\nns.\n• Develop practical and rigorous evaluation This would include:\nframeworks that will enable the monitoring\n• An overarching evaluation framework for the implementation of this\nof key progress in men’s health and in\nStrategy that would guide routine and periodic evaluation enquiry to\ninitiatives relating to this strategy\ninform of progress, to identify areas for improvement and to support\nthe demonstration of accountability to the men’s health field and\nthe community\n• An evaluation framework for each of the Grant Programs (Action\nareas: 1.3, 2.2 and 2.3)\n• Each evaluation framework would include its purpose, scope,\nprogram logic model, key questions to be answered and for each, the\nkey measures, data sources and methods that will be used.\n Source: `strategies/national-men-s-health-strategy-2020-2030_0.pdf (https://www.health.gov.au/sites/default/files/documents/2021/05/national-men-s-health-strategy-2020-2030_0.pdf)`\n- Health equity Target: Australians in regional and • B y increasing the amount of healthy years of life for\npeople within these communities, their health will be\nis achieved remote areas will have at least an\non a level that is closer to other Australians by 2030.\nfor priority additional three years of life lived\npopulations in full health by 2030\nTarget: Aboriginal and Torres\nStrait Islander people have at least\nan additional three years of life\nlived in full health by 2030\nUnderpinned by: Investment in • T his means that over the next 10 years, more money\nInvestment preventive health will rise to be will be invested to keep Australians healthy and well.\nin prevention 5% of total health expenditure • Increasing investment to 5% will significantly increase\nis increased across Commonwealth, state and the amount of prevention activities that can implemented\n Source: `strategies/national-preventive-health-strategy-2021-2030-national-preventive-health-strateg.pdf (https://www.health.gov.au/sites/default/files/documents/2021/12/national-preventive-health-strategy-2021-2030-national-preventive-health-strategy-2021-2030-summary.pdf)`\n- [Page 21]\nPeople living in areas of People with severe or\nmost disadvantage are profound activity limitations are\n1.16x more likely 1.22x more likely\nthan those living in areas than those without limitations\nof least disadvantage\n65–74 year olds are\nPeople living in regional\n& remote areas are 1.7x more likely\nto be affected than 18–24 year olds\n1.08x more likely\nto be affected than those\nAboriginal and Torres Strait\nliving in major cities\nIslander peoples are\n1.16x more likely\nMen are\nthan non-Indigenous people\n1.25x\nOverweight and obesity contribute\nmore likely\nof the health gap\nthan women 7.2%\nbetween Aboriginal\nand Torres Strait Islander peoples\nand non-Indigenous Australians\nFigure 7: Comparative rates of overweight and obesity in priority populations43,44,45\nAligning implementation with the National Preventive\nHealth Strategy 2021-2030\n Source: `strategies/national-obesity-strategy-2022-2032_0.pdf (https://www.health.gov.au/sites/default/files/documents/2022/03/national-obesity-strategy-2022-2032_0.pdf)`\n- Guiding principles 10\nPriority Area 10: 26\nEliminate exceptions to smoke-free workplaces,\nPART THREE: PRIORITY AREAS AND ACTIONS 12\npublic places and other settings\nPriority Area 1: 12\nPriority Area 11: 28\nProtect public health policy, including tobacco\nProvide greater access to evidence-based\ncontrol policies, from all commercial and other\ncessation services to support people to quit the\nvested interests\nuse of tobacco, e-cigarettes and novel and\nPriority Area 2: 14 emerging products\nDevelop, implement and fund evidence-based\nintegrated public health campaigns and other\nPART 4: GOVERNANCE 30\ncommunication tools to motivate people who use\ntobacco to quit and recent quitters to continue\nsmoking abstinence; discourage uptake of tobacco PART 5: MONITORING AND\nuse; and reshape social norms about the tobacco EVALUATING PROGRESS 31\nindustry and tobacco use\nImplementation timeframes 31\n Source: `strategies/national-tobacco-strategy-2023-2030.pdf (https://www.health.gov.au/sites/default/files/2023-05/national-tobacco-strategy-2023-2030.pdf)`\n- [pages 3,4]\nrated public health campaigns and other\nPART 4: GOVERNANCE 30\ncommunication tools to motivate people who use\ntobacco to quit and recent quitters to continue\nsmoking abstinence; discourage uptake of tobacco PART 5: MONITORING AND\nuse; and reshape social norms about the tobacco EVALUATING PROGRESS 31\nindustry and tobacco use\nImplementation timeframes 31\nPriority Area 3: 16\nReviews and reporting 31\nContinue to reduce the affordability of tobacco\nproducts Indicators 31\nPriority Area 4: 17\nStrengthen and expand efforts and partnerships REFERENCES 32\nto prevent and reduce tobacco use among\nFirst Nations people\nPriority Area 5: 19\nStrengthen efforts to prevent and reduce\ntobacco use among populations at a higher risk of\nharm from tobacco use and populations with a high\nprevalence of tobacco use\n1\n Source: `strategies/national-tobacco-strategy-2023-2030.pdf (https://www.health.gov.au/sites/default/files/2023-05/national-tobacco-strategy-2023-2030.pdf)`\n- The most recent, the\non tobacco farms, deforestation, carbon and other National Tobacco Strategy 2012–2018, emphasised\nwaste emissions, residential and bush fires, and 9 priority areas.9 Achievements under the 2012–2018\nnon-biodegradable litter.6 Strategy are summarised in Part 1.2 of this document.\n Source: `strategies/national-tobacco-strategy-2023-2030.pdf (https://www.health.gov.au/sites/default/files/2023-05/national-tobacco-strategy-2023-2030.pdf)`\n- 36\nin this Strategy aim to align with the spirit and the priority %\nSmoke-free laws were strengthened in most states and\nreform areas of the National Agreement on Closing the Gap.\nterritories to capture e-cigarettes and/or cover a wider\n24\nrange of public places and other settings such as outdoor\ndining areas, public transport settings, custodial settings,\n1.2 Progress and achievements under the\nand cars when children are present.\n Source: `strategies/national-tobacco-strategy-2023-2030.pdf (https://www.health.gov.au/sites/default/files/2023-05/national-tobacco-strategy-2023-2030.pdf)`\n- National Tobacco Strategy 2012–2018 12\nThe National Tobacco Strategy 2012–2018 delivered Other key achievements include significant investments\nmany achievements.\n Source: `strategies/national-tobacco-strategy-2023-2030.pdf (https://www.health.gov.au/sites/default/files/2023-05/national-tobacco-strategy-2023-2030.pdf)`\n- 12\nOther key achievements include significant investments\nby the Australian Government to prevent the trade in illicit\n0\ntobacco, and the publication of Australian Government\n2001 2004–05 2007–08 2011–12 2014–15 2017–18\nguidance regarding the legal obligations of public officials\nunder Article 5.3 of the WHO FCTC (see Part 3, Priority\nNever smoked Ex-smoker Current daily smoker\nArea 1 for further detail).\n Source: `strategies/national-tobacco-strategy-2023-2030.pdf (https://www.health.gov.au/sites/default/files/2023-05/national-tobacco-strategy-2023-2030.pdf)`\n- [Page 33]\nAction area 3.2: Improve data availability to inform our understanding of men’s health and track our\nprogress\nActions Detail\n• Create a standard set of stratifications for the This would include:\nsystematic and consistent analysis of national\n• The publication of regular statistical bulletins on men’s health by the\ndatasets to make routine data more\nAustralian Institute of Health and Welfare\ninformative with respect to men’s health and\nthe health of particular populations of men • The routine stratification of Census data by sex, age, geographic\nlocation, socioeconomic indices, culture and language in alignment\nwith World Health Organisation guidance on data disaggregation\n• Encouraging all organisations that manage large datasets (e.g. cancer\nand immunisation registers; road traffic accident datasets) to adopt\nconsistent methods for the stratification and analysis of data to\n Source: `strategies/national-men-s-health-strategy-2020-2030_0.pdf (https://www.health.gov.au/sites/default/files/documents/2021/05/national-men-s-health-strategy-2020-2030_0.pdf)`\n\n## Key Issues, Risks, and Recommendations\n\n- The non-medical use of\npharmaceutical drugs is an ongoing public health\nRelated Strategic Guidance\nchallenge in Australia, with evidence suggesting\n• The National Alcohol Strategy 2019-2028\nan increase in associated harms including\n• The National Drug Strategy 2017-2026\nmortality375.\n• National Ice Action Strategy 2015\nAs with many health issues, social and\n• National Fetal Alcohol Spectrum Disorder\nstructural determinants significantly contribute to\n(FASD) Strategic Action Plan 2018-2028\nharmful AOD use and can include complex issues\n• Australian Guidelines to Reduce Health Risks\nsuch as social and economic exclusion, poverty,\nfrom Drinking Alcohol\nmarginalisation, racism and stigmatisation115,\n• National Aboriginal and Torres Strait Islander\n373.\n Source: `strategies/national-preventive-health-strategy-2021-2030_1.pdf (https://www.health.gov.au/sites/default/files/documents/2021/12/national-preventive-health-strategy-2021-2030_1.pdf)`\n- [pages 26,27,28]\natest risk of ill\nand action health and premature mortality\n• Demonstrate accountability for an equity-driven approach in the monitoring and\nevaluation of this strategy\n• Focus on prevention first and foremost – from primary prevention (keeping people\nhealthy) through to early diagnosis and intervention\n• Take a life-course approach to prevention, adapting information and activities to\nFocus on prevention men and boys at different life stages\n• Recognise that prevention goes beyond individual responsibility to the creation of\nhealthy environments and communities\n• Highlight the significance of gender as a key determinant of men’s health and\nAcknowledge the influence of gender on wellbeing\nhealth\n• Address gender inequality issues faced by men\nNational Men’s Health Strategy 2020-2030 | 26\n|\n Source: `strategies/national-men-s-health-strategy-2020-2030_0.pdf (https://www.health.gov.au/sites/default/files/documents/2021/05/national-men-s-health-strategy-2020-2030_0.pdf)`\n- The harmful\nin the past 12 months and not being able to\nhealth ramifications of carrying excess weight\npurchase more303\nhave been highlighted even further during the\n• 9 5% of adults have inadequate fruit and\nCOVID-19 pandemic, with those living with\nvegetable intake, and 95% of children have\nsevere obesity being more at risk of severe\ninadequate vegetable intake32\nillness, including hospitalisation and death, if\n• A round one-third of Australians’ daily energy\nCOVID-19 is contracted211, 212.\nintake is from discretionary foods which should\nAnother prominent nutrition-related issue\nonly be consumed in small amounts - this is\nin Australia is malnutrition, especially in older\nhighest for teenagers at 41%4\nAustralians.\n Source: `strategies/national-preventive-health-strategy-2021-2030_1.pdf (https://www.health.gov.au/sites/default/files/documents/2021/12/national-preventive-health-strategy-2021-2030_1.pdf)`\n- One of the key\n• F unding for vaccine purchasing and services\nchallenges in improving immunisation coverage to support immunisation uptake has increased\nis to target immunisation to population groups from $10 million per year in the mid-1970s to\nwho are at increased risk from VPDs, including more than $460 million in 2017–18355\npregnant women and specific age cohorts357. • T he 2009 Adult Vaccination Survey estimated\nIn some cases, people working in areas with a that, for the population aged 65 years and\nhigh risk of transmission, such as health care, older, 74.6% were vaccinated against seasonal\naged care, or child care, are also at higher risk355. influenza and 54.4% against pneumococcal\nVaccination uptake among adults in Australia disease.\n Source: `strategies/national-preventive-health-strategy-2021-2030_1.pdf (https://www.health.gov.au/sites/default/files/documents/2021/12/national-preventive-health-strategy-2021-2030_1.pdf)`\n- However, alcohol\noccasion risk guidelines still remains an important public health issue that\n• I n 2019, people living in remote and very remote is associated with over 4,000 deaths, accounts\nareas were about 1.5 times as likely than those for 54% of drug-related hospitalisations, and has\nin major cities to exceed lifetime and single a significant impact on violence in Australian\noccasion risk guidelines (at least monthly)\ncommunities186, 341, 369, 370.\n• People aged 70 and over are the most likely to The consumption of alcohol during pregnancy\ndrink alcohol daily and the 50–59 age group are\ncan result in birth defects and behavioural and\nmost likely to exceed the lifetime risk guideline\nneurodevelopmental abnormalities known as\n• A higher proportion of people with a mental\nFetal Alcohol Spectrum Disorder which has\nhealth condition reported drinking at risky\n Source: `strategies/national-preventive-health-strategy-2021-2030_1.pdf (https://www.health.gov.au/sites/default/files/documents/2021/12/national-preventive-health-strategy-2021-2030_1.pdf)`\n- Financial constraints result populations. 🖹\nin people buying cheaper, unhealthy food and\n• Build on existing affordable housing\ndrinks, which has long-term health impacts.15,131\ninitiatives to improve community\nand household amenity (including\nFood insecurity is an issue for many Australians.\nreducing overcrowding, improving\nIt is one of the main drivers of unhealthy weight in\nhousehold food preparation and\nAboriginal and Torres Strait Islander communities\n🧍\nstorage facilities).\n- more than 1 in 5 (22%) Aboriginal and Torres\nStrait Islander households report food insecurity,\nand this is even higher in remote areas.132\nThe broader determinants of health are beyond\nthe control of individuals and are outside the\ndirect role of the health system.28 The example\nactions identify opportunities for health agencies\nto lead discussions and partner with other\n Source: `strategies/national-obesity-strategy-2022-2032_0.pdf (https://www.health.gov.au/sites/default/files/documents/2022/03/national-obesity-strategy-2022-2032_0.pdf)`\n- There\n• Harm minimisation and addressing the wider prevent harm and are adapted to local need\ndeterminants of health are at the forefront • Prevention is informed by evidence-based\nof Australia’s approach to alcohol and other strategies to reduce risk factors and enhance\nPolicy\ndrug policy and prevention investment - protective factors\nachievements\nby 2030 guided by a national strategy • The age of onset of alcohol and other drug\n• Leaders across Australia challenge the use is prevented or delayed to reduce harm\nnormalisation of hazardous and harmful among young people and across their later\nalcohol use years, including through evidence-based and\n• AOD policy and programs including aged-appropriate school programs\nprevention strategies avoid and reduce • The needs of high risk and priority\nstigma and discrimination populations, particularly the impact of\n Source: `strategies/national-preventive-health-strategy-2021-2030_1.pdf (https://www.health.gov.au/sites/default/files/documents/2021/12/national-preventive-health-strategy-2021-2030_1.pdf)`\n- A further barrier identified physical activity and sleep for all\nwas the lack of effective and individualised patient/clients, regardless of weight\ntreatment and/or referral options.158 status, through education, training,\nprofessional networks and quality\nCommunity consultation showed that both the improvement programs. 🖹 🧍\nhealth sector and the community felt we should:\n• Enable the health care workforce\n• encourage health professionals to to effectively prevent weight-related\ndiscuss weight and associated risks with complications and manage any co-\nclients morbidities. 🖹 🧍\n• train health professionals, especially\ncommunity health practitioners in\nregional, rural and remote areas\n• give the health workforce, most\ncommonly GPs, better information, tools\nand guidance about how to discuss\nweight issues with patients\n• upskill our health workforce to help\n Source: `strategies/national-obesity-strategy-2022-2032_0.pdf (https://www.health.gov.au/sites/default/files/documents/2022/03/national-obesity-strategy-2022-2032_0.pdf)`\n- [pages 23,24,25,26,27]\numstances specific to the\nto participate in multiple target population group/s and\nengagement activities on the same identify any potential limitations\nor similar issues), as this can result in or constraints to engagement.\nengagement fatigue and be a barrier Mitigate these by fostering a safe\nto establishing sustained, trusted and inclusive environment for all\nrelationships with consumers and consumers.\ncommunities.\n• Investigate any other\nengagement activities that are\nunder way or have been\nundertaken in the community\npreviously to inform engagement\nplanning and avoid over-\nengagement with certain\ncommunities and population\ngroups.\n• Talk to community leaders, local\nstakeholders and consumers\ndirectly (where appropriate), to\ncanvass their views on the policy\nissue/s being considered.\n Source: `strategies/national-consumer-engagement-strategy-for-health-and-wellbeing.pdf (https://www.health.gov.au/sites/default/files/2025-10/national-consumer-engagement-strategy-for-health-and-wellbeing.pdf)`\n- The Review also clearly outlined the impact of COVID-19 in Aboriginal and Torres\nthat Australia’s public health experts have been Strait Islander communities.\ninstrumental in safely stewarding Australia’s The lessons from the COVID-19 pandemic\nresponse through the COVID-19 pandemic, will continue to emerge over the next decade.\nconcluding that a highly qualified public health It will be important to understand and learn from\nworkforce is vital214. these lessons in order to ensure Australia, and\nCOVID-19 has shown Australians and the world the world, are less vulnerable to future public\nhow interconnected our health is, with the risk to health challenges.\n Source: `strategies/national-preventive-health-strategy-2021-2030_1.pdf (https://www.health.gov.au/sites/default/files/documents/2021/12/national-preventive-health-strategy-2021-2030_1.pdf)`\n- [pages 66,67,68]\nional Fetal Alcohol Spectrum Disorder\nstructural determinants significantly contribute to\n(FASD) Strategic Action Plan 2018-2028\nharmful AOD use and can include complex issues\n• Australian Guidelines to Reduce Health Risks\nsuch as social and economic exclusion, poverty,\nfrom Drinking Alcohol\nmarginalisation, racism and stigmatisation115,\n• National Aboriginal and Torres Strait Islander\n373.\n Source: `strategies/national-preventive-health-strategy-2021-2030_1.pdf (https://www.health.gov.au/sites/default/files/documents/2021/12/national-preventive-health-strategy-2021-2030_1.pdf)`\n- [Page 12]\nNational Strategic Framework for Chronic Conditions 2026–35 4\nChronic Conditions in Australia\nChronic conditions in Australia\n15.4\nmillion\n3 in 5 Australians 2 in 5 Australians The proportion of Australians\n(15.4 million) are living (9.7 million) are living with multimorbidity\nwith at least one with multimorbidity increased by 33%,\nchronic condition (2 or more chronic compared to an 18%\nconditions) increase in those with a\nsingle chronic condition\nbetween 2007–08 and 2022\nAustralians lost an Chronic conditions are 78% of the fatal burden of\nestimated 4�4 million responsible for 91% of the disease (years of life lost due\nyears of healthy life due non-fatal burden of disease to premature death)\nto chronic conditions in (years lived with disability\n2023, equivalent to 85% or ill health)i across the\nof the total burden of population\ndisease that year\n Source: `strategies/national-strategic-framework-for-chronic-conditions_0.pdf (https://www.health.gov.au/sites/default/files/2026-03/national-strategic-framework-for-chronic-conditions_0.pdf)`\n- RB Khatri and Y Assefa, ‘Access to health services among culturally and linguistically\ndiverse populations in the Australian universal health care system: issues and\nchallenges’, BMC Public Health, 2022, 22(1):880, doi:10.1186/s12889-022-13256-z.\n Source: `strategies/national-strategic-framework-for-chronic-conditions_0.pdf (https://www.health.gov.au/sites/default/files/2026-03/national-strategic-framework-for-chronic-conditions_0.pdf)`\n- [Page 4]\nTHE NATIONAL ALCOHOL\nSTRATEGY 2019–2028 AT A GLANCE\nAim\nTo prevent and minimise alcohol-related harms among individuals, families and communities by:\n• identifying agreed national priority areas of focus and policy options;\n• promoting and facilitating collaboration, partnership and commitment from the\ngovernment and non-government sectors; and,\n• targeting a 10% reduction in harmful alcohol consumption:\n- alcohol consumption at levels that puts individuals at risk of injury from a single\noccasion of drinking, at least monthly; and\n- alcohol consumption at levels that puts individuals at risk of disease or injury\nover a lifetime.\ni m\np r o v e c o m m t o t u a r n g i e c t a g t r i o o u n p s P r H o e a m lt\ni\nh o\nm\ni t e\na\ni r n\np n\nC g\nr d\no\no o\nm\nf v u a e\nm\nC\nn\nP\nl d c\ne\nn\na\ne\no e\ni\nn\nw\nt\no\nh r\ni\nt\ne\np\na s\nr\no\ns\nt r\ne\nl\nl a\ne\ne\nd\nh n n a d e r i s m\na\nn s\nn\ng s\n Source: `strategies/national-alcohol-strategy-2019-2028.pdf (https://www.health.gov.au/sites/default/files/documents/2020/11/national-alcohol-strategy-2019-2028.pdf)`\n\n## Corporate Values and Operating Culture\n\n- [Page 33]\nAction area 3.2: Improve data availability to inform our understanding of men’s health and track our\nprogress\nActions Detail\n• Create a standard set of stratifications for the This would include:\nsystematic and consistent analysis of national\n• The publication of regular statistical bulletins on men’s health by the\ndatasets to make routine data more\nAustralian Institute of Health and Welfare\ninformative with respect to men’s health and\nthe health of particular populations of men • The routine stratification of Census data by sex, age, geographic\nlocation, socioeconomic indices, culture and language in alignment\nwith World Health Organisation guidance on data disaggregation\n• Encouraging all organisations that manage large datasets (e.g. cancer\nand immunisation registers; road traffic accident datasets) to adopt\nconsistent methods for the stratification and analysis of data to\n Source: `strategies/national-men-s-health-strategy-2020-2030_0.pdf (https://www.health.gov.au/sites/default/files/documents/2021/05/national-men-s-health-strategy-2020-2030_0.pdf)`\n- Guiding Principles\nPerson-centred,\nEquity Evidence based\nmultidisciplinary care\nCollaboration and\nSustainability Climate resilience\nshared responsibility\nAccountability and\ntransparency\nFocus Areas\n1 Health promotion and 2 Embedding prevention, 3 Continuity of care\neducation supporting early detection and\nself-management of risk intervention in the\nfactors and conditions continuum of care\n4 Managing multimorbidity 5 Enhanced and targeted\nsupport for priority\npopulations\n Source: `strategies/national-strategic-framework-for-chronic-conditions_0.pdf (https://www.health.gov.au/sites/default/files/2026-03/national-strategic-framework-for-chronic-conditions_0.pdf)`\n- Table 1 - The effect of social determinants on health\nSocial element Protective Adverse\nFamily situation27 High-functioning, cohesive and High stress environment\nsupportive relationships Socioeconomic disadvantage\nPresence of violence and abuse\nEarly childhood10, 21, 28 Preconception - parents’ health Unhealthy learned behaviours\nand diet Deprivation\nPreschool education/programs\nQuality of relationships\nHousing21, 29-31 Strong structural integrity Overcrowding\nHome ownership Insecure housing\nQuality infrastructure provides Unaffordable housing\nshelter, safety, security and privacy Homelessness\nAppropriate for family unit Inadequate supply and poor conditions\nof social housing\nWorking Secure, full-time arrangement Exposure to harmful substances & injury\nconditions10, 21, 32-35 Strong social connections in the risks\nworkplace Underemployment\nWorking excessively long hours\n Source: `strategies/national-preventive-health-strategy-2021-2030_1.pdf (https://www.health.gov.au/sites/default/files/documents/2021/12/national-preventive-health-strategy-2021-2030_1.pdf)`\n- Table 8 - The effect of digital determinants on health\nDigital element Protective Adverse\nTelehealth156-160 Greater accessibility to services Requires access to devices, internet and\nConvenience digital literacy\nLack of infrastructure/bandwidth required\nto connect to services\nSome limitations in assessment compared\nto face-to-face consultations\nPotential privacy concerns\nPotential for misuse and over-use of\nservice\nPotential for predatory business models\nand behaviours\nDiagnostic and Earlier diagnosis and care Potential over-diagnosis\ntherapeutic tools155, 161 Increased objectivity in disease\ndetection\nReduced diagnostic and therapeutic\nerrors\nWearable Empower consumers to track and Potential privacy concerns\ntechnologies162-164 enhance their health Only wearables defined as ‘medical\ndevices’ are subject to regulation\nPotential information overload or\nmisinformation\n Source: `strategies/national-preventive-health-strategy-2021-2030_1.pdf (https://www.health.gov.au/sites/default/files/documents/2021/12/national-preventive-health-strategy-2021-2030_1.pdf)`\n- Enabling consumers to easily\n🔍 🖹 🧍\nNutrient Reference Values.\nsee and understand nutritional and energy\n• Consider other policies or regulations\ncontent helps to inform healthier choices and\nto support people to make healthier\ninfluences purchasing behaviour.\nfood and drink choices (such as\nAustralians buy their food and drinks largely from information on unhealthy ingredients\nsupermarkets - with more than two-thirds of all including added sugar, salt, saturated\nfood and drink spending (excluding alcohol) at and/or trans fats, alcohol). 🔍 🖹 🧍\nsupermarkets,81 and 60% of all grocery sales at\n• Work with supermarkets and food\nthe two big supermarket chains.82\nretailers to increase the prominence,\npromotion and availability of healthy\nMany supermarket purchases are made on\nfood and drinks in food retail,\nimpulse with product packaging and food\nconsistent with the Australian Dietary\n Source: `strategies/national-obesity-strategy-2022-2032_0.pdf (https://www.health.gov.au/sites/default/files/documents/2022/03/national-obesity-strategy-2022-2032_0.pdf)`\n- These contacts are an Strategies 3.3, 3.4 and 3.5 focus on\nopportunity for health professionals to sensitively training health professionals to have\nraise, discuss, assess and refer their patients positive discussions and provide non-\nto appropriate programs, behavioural support judgemental support for people living\nand where necessary, medical and/or surgical with obesity.\nintervention.\n• Addressing wider determinants of\nhealth and sustainability: Strategy\nTo improve the health system response, we need\n3.1, 3.2, 3.3, 3.4 and 3.5 include\nto embed a greater focus on overweight and\nthe need to consider social, cultural,\nobesity in clinical practice, and support upskilling\neconomic, structural and environmental\nof the workforce through continuing professional\nfactors, and multi-sector collaboration\ndevelopment.\n Source: `strategies/national-obesity-strategy-2022-2032_0.pdf (https://www.health.gov.au/sites/default/files/documents/2022/03/national-obesity-strategy-2022-2032_0.pdf)`\n- [Page 62]\nExample actions\nStrategy 3.4\n• Strengthen pre-service and\nexisting training and professional\nSupport health, social and other\ndevelopment opportunities for health,\ncare providers to enable positive\nsocial and other care professionals\ndiscussion about weight.\nthrough:\nPeople living with obesity experience stigma » building understanding of the\nand discrimination in the health system and\nmultiple causes of obesity\nfrom health care professionals.154,155 This affects\nand the systemic barriers that\ntheir quality of care and leads to negative social,\nperpetuate inequity\npsychological, and physical health outcomes,\n» skill development in shared\nincluding avoiding health care.156,157\ndecision making and discussing\n🖹 🧍\nHealth professionals are worried about weight without judgement.\ncompromising patient trust and how raising\n• Build cultural competency and skills\n Source: `strategies/national-obesity-strategy-2022-2032_0.pdf (https://www.health.gov.au/sites/default/files/documents/2022/03/national-obesity-strategy-2022-2032_0.pdf)`\n- [Page 53]\nNational Strategic Framework for Chronic Conditions 2026–35 45\nHiAP approaches are supported by four pillars:\n• governance and accountability through whole-of-government plans, fostering\na culture of collaboration, and harnessing existing structures and mechanisms\n• leadership at all levels, including advocating for, and fostering a culture of\ncollaboration, establishing a network of HiAP champions, and joint identification\nof issues to achieve shared goals\n• ways of working and work methods including developing collaborative partnerships\nbased on trust and open communication, understanding policy priorities of partners,\nand co-designing policy plans\n• resources, financing, and capabilities through having dedicated HiAP roles and\nbudget, and capabilities for knowledge translation.\n Source: `strategies/national-strategic-framework-for-chronic-conditions_0.pdf (https://www.health.gov.au/sites/default/files/2026-03/national-strategic-framework-for-chronic-conditions_0.pdf)`\n\n## Global Ideas and Case Study Inputs\n\n_No global-intelligence source text found yet. Run `CLAUDE/global-ideas-scraper.py ` to populate case-study sources._\n\n## Source Artifacts Used\n\n- `strategies/national-alcohol-strategy-2019-2028.pdf` - strategies - https://www.health.gov.au/sites/default/files/documents/2020/11/national-alcohol-strategy-2019-2028.pdf\n- `strategies/national-action-plan-for-the-health-of-children-and-young-people-2020-2030-natio.pdf` - strategies - https://www.health.gov.au/sites/default/files/documents/2021/04/national-action-plan-for-the-health-of-children-and-young-people-2020-2030-national-action-plan-for-the-health-of-children-and-young-people-2020-2030.pdf\n- `strategies/national-men-s-health-strategy-2020-2030_0.pdf` - strategies - https://www.health.gov.au/sites/default/files/documents/2021/05/national-men-s-health-strategy-2020-2030_0.pdf\n- `strategies/national-preventive-health-strategy-2021-2030-national-preventive-health-strateg.pdf` - strategies - https://www.health.gov.au/sites/default/files/documents/2021/12/national-preventive-health-strategy-2021-2030-national-preventive-health-strategy-2021-2030-summary.pdf\n- `strategies/national-preventive-health-strategy-2021-2030_1.pdf` - strategies - https://www.health.gov.au/sites/default/files/documents/2021/12/national-preventive-health-strategy-2021-2030_1.pdf\n- `strategies/national-women-s-health-strategy-2020-2030_0.pdf` - strategies - https://www.health.gov.au/sites/default/files/documents/2021/05/national-women-s-health-strategy-2020-2030_0.pdf\n- `strategies/national-obesity-strategy-2022-2032_0.pdf` - strategies - https://www.health.gov.au/sites/default/files/documents/2022/03/national-obesity-strategy-2022-2032_0.pdf\n- `strategies/national-tobacco-strategy-2023-2030.pdf` - strategies - https://www.health.gov.au/sites/default/files/2023-05/national-tobacco-strategy-2023-2030.pdf\n- `strategies/Standard-20for-20AI-20transparency-20statements-20v1.1.pdf` - strategies - https://www.digital.gov.au/sites/default/files/documents/2024-08/Standard%20for%20AI%20transparency%20statements%20v1.1.pdf\n- `strategies/national-consumer-engagement-strategy-for-health-and-wellbeing.pdf` - strategies - https://www.health.gov.au/sites/default/files/2025-10/national-consumer-engagement-strategy-for-health-and-wellbeing.pdf\n- `strategies/national-strategic-framework-for-chronic-conditions_0.pdf` - strategies - https://www.health.gov.au/sites/default/files/2026-03/national-strategic-framework-for-chronic-conditions_0.pdf\n- `pages/about.html` - pages - https://www.health.gov.au/topics/immunisation/about-immunisation/immunisation-policy-and-governance\n- `pages/announcements-index.html` - pages - https://www.health.gov.au/about-us/corporate-reporting/our-commitments/ai-transparency-statement\n- `pages/announcements-index__26.html` - pages - https://www.health.gov.au/about-us/corporate-reporting/our-commitments/ai-transparency-statement\n- `pages/announcements-index__27.html` - pages - https://www.health.gov.au/about-us/corporate-reporting/our-commitments/ai-transparency-statement?language=en\n- `pages/announcements-index__28.html` - pages - https://www.health.gov.au/topics/about-the-department/corporate-reporting/our-commitments/child-safety\n- `pages/announcements-index__29.html` - pages - https://www.health.gov.au/topics/about-the-department/corporate-reporting/our-commitments/regulator-statement\n- `pages/homepage.html` - pages - https://www.health.gov.au/health-topics/immunisation/about-immunisation/immunisation-policy-and-governance#national-immunisation-committee\n- `pages/ministers.html` - pages - https://www.health.gov.au/ministers\n- `pages/news-latest.html` - pages - https://www.health.gov.au/news\n- `pages/priorities-index.html` - pages - https://www.health.gov.au/our-work\n- `pages/priorities-index__25.html` - pages - https://www.health.gov.au/our-work/aged-care-reforms?language=en\n- `pages/publications-index.html` - pages - https://www.health.gov.au/resources/publications/national-immunisation-program-nip-vaccine-listing-process\n- `pages/strategies-index.html` - pages - https://www.health.gov.au/node/21213\n- `pages/strategies-index__00.html` - pages - https://www.health.gov.au/resources/publications/national-preventive-health-strategy-2021-2030\n- `pages/strategies-index__01.html` - pages - https://www.health.gov.au/resources/collections/national-preventive-health-strategy-consultation-workshops-resource-collection\n- `pages/strategies-index__02.html` - pages - https://www.health.gov\n\n_…truncated, open the .md file for the full content._", "legislation_md": "# National Immunisation Committee - Acts and Legislation Discovery\n\n**Generated at**: 2026-05-09T21:24:58.957293+00:00\n**Entity ID**: B-000708\n**Jurisdiction**: Commonwealth\n**Portfolio**: Health, Disability and Ageing\n\n> This is an evidence-based discovery list from scraped department material. A mention does not always mean the department administers the legislation; high-confidence and official register links should be reviewed.\n\n## Summary\n\n- Source files scanned: 40\n- Unique legislation references found: 6\n\n| Type | Count |\n|---|---:|\n| Act | 3 |\n| Determination | 1 |\n| Regulation | 2 |\n\n## Legislation References\n\n### National Health Act 1953\n\n**Type**: Act\n**Confidence**: medium\n**Mentions**: 2\n**Register search**: https://www.legislation.gov.au/search?query=National+Health+Act+1953\n\n**Sources**:\n- `pages/about.html`\n- `pages/homepage.html`\n\n**Evidence contexts**:\n- armaceutical Benefits Advisory Committee\nThe\nPharmaceutical Benefits Advisory Committee\n(PBAC) is an independent expert body appointed by the Australian Government. Members include doctors, health professionals, health economists and consumer representatives. The National Health Act 1953 requires a recommendation from the PBAC before a vaccine can be provided through the National Immunisation Program.\nATAGI advise the PBAC on clinical effectiveness of a vaccine in a population wide program.\nNational Health and Medical Research Council\nThe\nNat\n Source: `pages/about.html`\n- armaceutical Benefits Advisory Committee\nThe\nPharmaceutical Benefits Advisory Committee\n(PBAC) is an independent expert body appointed by the Australian Government. Members include doctors, health professionals, health economists and consumer representatives. The National Health Act 1953 requires a recommendation from the PBAC before a vaccine can be provided through the National Immunisation Program.\nATAGI advise the PBAC on clinical effectiveness of a vaccine in a population wide program.\nNational Health and Medical Research Council\nThe\nNat\n Source: `pages/homepage.html`\n\n### Designated Vaccines) Determination 2014\n\n**Type**: Determination\n**Confidence**: low\n**Mentions**: 2\n**Register search**: https://www.legislation.gov.au/search?query=Designated+Vaccines%29+Determination+2014\n\n**Sources**:\n- `pages/publications-index.html`\n- `other-pdfs/nip-vaccine-listing.pages.jsonl`\n\n**Evidence contexts**:\n- lied through the NIP. These include:\nTherapeutic Goods Administration (TGA) Registration\nPharmaceutical Benefits Advisory Committee (PBAC) recommendation\nPrice agreement\nGovernment approval\nListing on the Determination (National Health (Immunisation Program - Designated Vaccines) Determination 2014 (No. 1))\nVaccine procurement\nNational Immunisation Program (NIP) vaccine listing process\nNational Immunisation Program (NIP) vaccine listing process [PDF - 85 KB]\n- 1 page\nNational Immunisation Program (NIP) vaccine listing process [Word - 27 KB]\n- 2 pages\nAb\n Source: `pages/publications-index.html`\n- the outcomes of a NIP vaccine procurement\n4. Government\nprocess - no vaccine is guaranteed to be purchased for supply on the NIP (refer Step 6).\napproval\n• Following Government approval, a vaccine must be listed on the National Health\n(Immunisation Program - Designated Vaccines) Determination 2014 (No. 1) (the Determination).\n• All amendments to the Determination are registered on the Federal Register of Legislation\n5. Listing on\n(https://www.legislation.gov.au/).\nDetermination\n• Following a positive PBAC recommendation, a company is eligible to partic\n Source: `other-pdfs/nip-vaccine-listing.pages.jsonl`\n\n### Therapeutic Goods Regulations 1990\n\n**Type**: Regulation\n**Confidence**: low\n**Mentions**: 1\n**Register search**: https://www.legislation.gov.au/search?query=Therapeutic+Goods+Regulations+1990\n\n**Sources**:\n- `pages/taskforces-index.html`\n\n**Evidence contexts**:\n- relating to the safety, quality and efficacy of vaccines supplied in Australia including issues relating to pre-market assessment, post-market monitoring and safe use in national immunisation programs.\nThe Committee is established under Regulation 39F of the\nTherapeutic Goods Regulations 1990\nand the members are appointed by the Minister for Health.\nThe ACV was established in January 2017, following consolidation of previous functions of the Advisory Committee on the Safety of Vaccines (ACSOV) and the pre-market functions for vaccines of the Advis\n Source: `pages/taskforces-index.html`\n\n### Tobacco Plain Packaging Act 2011\n\n**Type**: Act\n**Confidence**: low\n**Mentions**: 1\n**Register search**: https://www.legislation.gov.au/search?query=Tobacco+Plain+Packaging+Act+2011\n\n**Sources**:\n- `strategies/national-tobacco-strategy-2023-2030.pages.jsonl`\n\n**Evidence contexts**:\n- ts and encourage tobacco legislation, which covers the Tobacco Advertising\nformer tobacco users to relapse. Article 13 of the WHO Prohibition Act 1992, the Tobacco Advertising Prohibition\nFCTC recognises that comprehensive bans on tobacco Regulation 1993, the Tobacco Plain Packaging Act 2011\nand the Tobacco Plain Packaging Regulations 2011.\nadvertising, promotion and sponsorship are needed to\ndecrease tobacco use.149 However, the tobacco industry The review will ensure that Australia’s tobacco\ncontrol legislative framework supports the objectives\n Source: `strategies/national-tobacco-strategy-2023-2030.pages.jsonl`\n\n### Tobacco Plain Packaging Regulations 2011\n\n**Type**: Regulation\n**Confidence**: low\n**Mentions**: 1\n**Register search**: https://www.legislation.gov.au/search?query=Tobacco+Plain+Packaging+Regulations+2011\n\n**Sources**:\n- `strategies/national-tobacco-strategy-2023-2030.pages.jsonl`\n\n**Evidence contexts**:\n- ch covers the Tobacco Advertising\nformer tobacco users to relapse. Article 13 of the WHO Prohibition Act 1992, the Tobacco Advertising Prohibition\nFCTC recognises that comprehensive bans on tobacco Regulation 1993, the Tobacco Plain Packaging Act 2011\nand the Tobacco Plain Packaging Regulations 2011.\nadvertising, promotion and sponsorship are needed to\ndecrease tobacco use.149 However, the tobacco industry The review will ensure that Australia’s tobacco\ncontrol legislative framework supports the objectives\ncontinues to market its products through a range\n Source: `strategies/national-tobacco-strategy-2023-2030.pages.jsonl`\n\n### WHO Prohibition Act 1992\n\n**Type**: Act\n**Confidence**: low\n**Mentions**: 1\n**Register search**: https://www.legislation.gov.au/search?query=WHO+Prohibition+Act+1992\n\n**Sources**:\n- `strategies/national-tobacco-strategy-2023-2030.pages.jsonl`\n\n**Evidence contexts**:\n- Care has commenced a review of Commonwealth\ncontinuation of smoking (particularly among young people),\nreduce smoking cessation attempts and encourage tobacco legislation, which covers the Tobacco Advertising\nformer tobacco users to relapse. Article 13 of the WHO Prohibition Act 1992, the Tobacco Advertising Prohibition\nFCTC recognises that comprehensive bans on tobacco Regulation 1993, the Tobacco Plain Packaging Act 2011\nand the Tobacco Plain Packaging Regulations 2011.\nadvertising, promotion and sponsorship are needed to\ndecrease tobac\n Source: `strategies/national-tobacco-strategy-2023-2030.pages.jsonl`\n\n## Files Scanned\n\n- `pages/about.html` (page)\n- `pages/announcements-index.html` (page)\n- `pages/announcements-index__26.html` (page)\n- `pages/announcements-index__27.html` (page)\n- `pages/announcements-index__28.html` (page)\n- `pages/announcements-index__29.html` (page)\n- `pages/homepage.html` (page)\n- `pages/ministers.html` (page)\n- `pages/news-latest.html` (page)\n- `pages/priorities-index.html` (page)\n- `pages/priorities-index__25.html` (page)\n- `pages/publications-index.html` (page)\n- `pages/strategies-index.html` (page)\n- `pages/strategies-index__00.html` (page)\n- `pages/strategies-index__01.html` (page)\n- `pages/strategies-index__02.html` (page)\n- `pages/strategies-index__03.html` (page)\n- `pages/strategies-index__04.html` (page)\n- `pages/strategies-index__05.html` (page)\n- `pages/strategies-index__06.html` (page)\n- `pages/strategies-index__07.html` (page)\n- `pages/strategies-index__08.html` (page)\n- `pages/strategies-index__09.html` (page)\n- `pages/strategies-index__10.html` (page)\n- `pages/strategies-index__11.html` (page)\n- `pages/strategies-index__12.html` (page)\n- `pages/strategies-index__13.html` (page)\n- `pages/taskforces-index.html` (page)\n- `other-pdfs/nip-vaccine-listing.pages.jsonl` (pdf_pages)\n- `strategies/national-action-plan-for-the-health-of-children-and-young-people-2020-2030-natio.pages.jsonl` (pdf_pages)\n- `strategies/national-alcohol-strategy-2019-2028.pages.jsonl` (pdf_pages)\n- `strategies/national-consumer-engagement-strategy-for-health-and-wellbeing.pages.jsonl` (pdf_pages)\n- `strategies/national-men-s-health-strategy-2020-2030_0.pages.jsonl` (pdf_pages)\n- `strategies/national-obesity-strategy-2022-2032_0.pages.jsonl` (pdf_pages)\n- `strategies/national-preventive-health-strategy-2021-2030-national-preventive-health-strateg.pages.jsonl` (pdf_pages)\n- `strategies/national-preventive-health-strategy-2021-2030_1.pages.jsonl` (pdf_pages)\n- `strategies/national-strategic-framework-for-chronic-conditions_0.pages.jsonl` (pdf_pages)\n- `strategies/national-tobacco-strategy-2023-2030.pages.jsonl` (pdf_pages)\n- `strategies/national-women-s-health-strategy-2020-2030_0.pages.jsonl` (pdf_pages)\n- `strategies/Standard-20for-20AI-20transparency-20statements-20v1.1.pages.jsonl` (pdf_pages)", "global_initiatives_md": null, "strategy": { "reporting_period": "2024-25", "corporate_plan_period": "2025-26", "vision": null, "vision_source_page": null, "purposes": "To improve the health of all Australians by reducing the prevalence of tobacco use and its associated health, social, environmental and economic costs, and the inequalities it causes", "purposes_source_page": 3, "how_we_deliver": "This Strategy builds on the success of previous national tobacco strategies and strengthens population-wide approaches that have been successful in reducing the prevalence of tobacco use over the past 4 decades.", "how_we_deliver_source_page": 4, "government_priorities": [ { "text": "Eliminate all tobacco-related advertising, promotion and sponsorship", "source_page": 10 }, { "text": "Further regulate the contents and product disclosures pertaining to tobacco products", "source_page": 11 }, { "text": "Strengthen regulation to reduce the supply, availability and accessibility of tobacco products", "source_page": 12 }, { "text": "Strengthen regulations on e-cigarettes and novel and emerging products", "source_page": 13 }, { "text": "Eliminate exceptions to smoke-free workplaces, public places and other settings", "source_page": 14 }, { "text": "Provide greater access to evidence-based cessation services to support people to quit the use of tobacco, e-cigarettes and novel and emerging products", "source_page": 15 }, { "text": "Develop, implement and fund evidence-based integrated public health campaigns and other communication tools to motivate people who use tobacco to quit and recent quitters to continue smoking abstinence; discourage uptake of tobacco use; and reshape social norms about the tobacco industry and tobacco use", "source_page": 16 }, { "text": "Continue to reduce the affordability of tobacco products", "source_page": 17 }, { "text": "Strengthen and expand efforts and partnerships to prevent and reduce tobacco use among First Nations people", "source_page": 19 }, { "text": "Strengthen efforts to prevent and reduce tobacco use among populations at a higher risk of harm from tobacco use and populations with a high prevalence of tobacco use", "source_page": 20 } ], "outcomes": [ { "name": "Outcome 1: Tobacco use", "description": "Tobacco use causes more deaths than any other behavioural risk factor in Australia, contributing 8.6% of the total disease burden in 2018. Up to two-thirds of deaths in tobacco smokers can be attributed to smoking, and long-term smokers die an average of 10 years earlier than non-smokers.", "key_activities": [ "Continue to reduce the affordability of tobacco products", "Strengthen and expand efforts and partnerships to prevent and reduce tobacco use among First Nations people", "Strengthen efforts to prevent and reduce tobacco use among populations at a higher risk of harm from tobacco use and populations with a high prevalence of tobacco use" ], "source_page": 5 } ], "values": [], "values_framework_name": null, "kpi_targets_2025_26": [ { "code": "CCE01", "measure": "Prevalence of daily smoking among adults", "target": "10% reduction from 2017-18 levels", "source_page": 7 } ], "kpi_results_2024_25": [ { "code": "CCE01", "measure": "Prevalence of daily smoking among adults", "result": "12.7% (reduction from 14.7% in 2017-18)", "status": "Partially achieved", "source_page": 7 } ], "_source_urls": { "annual_report_url": "", "corporate_plan_url": "" } }, "ideas": [ { "entity_id": "B-000708", "entity_name": "National Immunisation Committee", "folder_name": "National-Immunisation-Committee", "category": "Data & Performance", "scale": "small", "title": "KPI evidence register with named owners", "idea": "Create a simple register mapping each KPI to source data, owner, frequency, target, and last result.", "quote": "[Page 33]\nAction area 3.2: Improve data availability to inform our understanding of men’s health and track our\nprogress\nActions Detail\n• Create a standard set of stratifications for the This would include:\nsystematic and consistent analysis of national\n• The publication of regular statistical bulletins on men’s health by the\ndatasets to make routine data more\nAustralian Institute of Health and Welfare\ninformative with respect to men’s health and\nthe health of particular populations of men • The routine stratification of Census data by sex, age, geographic\nlocation, socioeconomic indices, culture and language in alignment\nwith World Health Organisation guidance on data disaggregation\n• Encouraging all organisations that manage large datasets (e.g. cancer\nand immunisation registers; road traffic accident datasets) to adopt\nconsistent methods for the stratification and analysis of data to", "impact": "High", "effort": "Low", "proof": "Evidence-backed", "beneficiaries": "Executives / Parliament / public", "source": "strategies/national-men-s-health-strategy-2020-2030_0.pdf (https://www.health.gov.au/sites/default/files/documents/2021/05/national-men-s-health-strategy-2020-2030_0.pdf)", "implementation": [ "Pick one high-volume process or document family.", "Name an owner and baseline current volume, time, cost, and satisfaction.", "Run a 4-8 week pilot with clear before/after metrics.", "Publish lessons and decide whether to scale." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability" ] }, { "entity_id": "B-000708", "entity_name": "National Immunisation Committee", "folder_name": "National-Immunisation-Committee", "category": "Data & Performance", "scale": "large", "title": "Outcome dashboard linking budget, delivery, and public impact", "idea": "Build a public-facing outcome dashboard showing spend, outputs, outcomes, and delivery confidence.", "quote": "[Page 33]\nAction area 3.2: Improve data availability to inform our understanding of men’s health and track our\nprogress\nActions Detail\n• Create a standard set of stratifications for the This would include:\nsystematic and consistent analysis of national\n• The publication of regular statistical bulletins on men’s health by the\ndatasets to make routine data more\nAustralian Institute of Health and Welfare\ninformative with respect to men’s health and\nthe health of particular populations of men • The routine stratification of Census data by sex, age, geographic\nlocation, socioeconomic indices, culture and language in alignment\nwith World Health Organisation guidance on data disaggregation\n• Encouraging all organisations that manage large datasets (e.g. cancer\nand immunisation registers; road traffic accident datasets) to adopt\nconsistent methods for the stratification and analysis of data to", "impact": "Very High", "effort": "High", "proof": "Evidence-backed", "beneficiaries": "Executives / Parliament / public", "source": "strategies/national-men-s-health-strategy-2020-2030_0.pdf (https://www.health.gov.au/sites/default/files/documents/2021/05/national-men-s-health-strategy-2020-2030_0.pdf)", "implementation": [ "Create a senior responsible owner and cross-functional delivery team.", "Map legislation, data, privacy, procurement, cyber, and workforce constraints.", "Co-design with users and frontline staff before technology selection.", "Stage delivery through pilots, benefits tracking, and public reporting." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability" ] }, { "entity_id": "B-000708", "entity_name": "National Immunisation Committee", "folder_name": "National-Immunisation-Committee", "category": "Risk & Assurance", "scale": "small", "title": "Recommendation tracker for audits, reviews, and inquiries", "idea": "Publish a single internal tracker for audit/review recommendations, owners, due dates, and implementation evidence.", "quote": "CVD, stroke, diabetes,\ndementia, hypertensive diseases, kidney disease\nLow blood pressure is a risk factor for glaucoma\nBlood glucose levels4, 118, High blood glucose is a risk factor for CVD, retinopathy, kidney disease\n122, 123\nWeight range124-134 Overweight and obesity increases risk of diabetes, cancer, asthma, depression, and\nadverse outcomes during pregnancy such as preeclampsia and stillbirth\nUnderweight increases risk of CVD, stroke, heart attack, atrial fibrillation, infection,\nand adverse outcomes in pregnancy such as preterm delivery and low birthweight\nBlood cholesterol135 High blood cholesterol is associated with ischaemic heart disease\nGenetics, epigenetics and Increased risk of cancer due to genetic changes to telomeres\ntelomere biology136-144 Increased risk of alcohol dependence, diabetes, inflammatory bowel disease and\nAlzheimer’s disease due to genetic predisposition", "impact": "High", "effort": "Low", "proof": "Evidence-backed", "beneficiaries": "Executives / assurance teams", "source": "strategies/national-preventive-health-strategy-2021-2030_1.pdf (https://www.health.gov.au/sites/default/files/documents/2021/12/national-preventive-health-strategy-2021-2030_1.pdf)", "implementation": [ "Pick one high-volume process or document family.", "Name an owner and baseline current volume, time, cost, and satisfaction.", "Run a 4-8 week pilot with clear before/after metrics.", "Publish lessons and decide whether to scale." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability", "Regulatory capture", "Over-automation of judgement" ] }, { "entity_id": "B-000708", "entity_name": "National Immunisation Committee", "folder_name": "National-Immunisation-Committee", "category": "Risk & Assurance", "scale": "large", "title": "Integrated assurance and lessons-learned system", "idea": "Create an assurance system that connects audit findings, risk registers, delivery reviews, and investment decisions.", "quote": "CVD, stroke, diabetes,\ndementia, hypertensive diseases, kidney disease\nLow blood pressure is a risk factor for glaucoma\nBlood glucose levels4, 118, High blood glucose is a risk factor for CVD, retinopathy, kidney disease\n122, 123\nWeight range124-134 Overweight and obesity increases risk of diabetes, cancer, asthma, depression, and\nadverse outcomes during pregnancy such as preeclampsia and stillbirth\nUnderweight increases risk of CVD, stroke, heart attack, atrial fibrillation, infection,\nand adverse outcomes in pregnancy such as preterm delivery and low birthweight\nBlood cholesterol135 High blood cholesterol is associated with ischaemic heart disease\nGenetics, epigenetics and Increased risk of cancer due to genetic changes to telomeres\ntelomere biology136-144 Increased risk of alcohol dependence, diabetes, inflammatory bowel disease and\nAlzheimer’s disease due to genetic predisposition", "impact": "Very High", "effort": "High", "proof": "Evidence-backed", "beneficiaries": "Executives / assurance teams", "source": "strategies/national-preventive-health-strategy-2021-2030_1.pdf (https://www.health.gov.au/sites/default/files/documents/2021/12/national-preventive-health-strategy-2021-2030_1.pdf)", "implementation": [ "Create a senior responsible owner and cross-functional delivery team.", "Map legislation, data, privacy, procurement, cyber, and workforce constraints.", "Co-design with users and frontline staff before technology selection.", "Stage delivery through pilots, benefits tracking, and public reporting." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability", "Regulatory capture", "Over-automation of judgement" ] }, { "entity_id": "B-000708", "entity_name": "National Immunisation Committee", "folder_name": "National-Immunisation-Committee", "category": "Regulation & Policy", "scale": "small", "title": "Regulatory burden scan for forms, guidance, and reporting", "idea": "Identify the top 10 highest-friction reporting obligations and simplify guidance, forms, or evidence requirements.", "quote": "[pages 33,34,35]\nns.\n• Develop practical and rigorous evaluation This would include:\nframeworks that will enable the monitoring\n• An overarching evaluation framework for the implementation of this\nof key progress in men’s health and in\nStrategy that would guide routine and periodic evaluation enquiry to\ninitiatives relating to this strategy\ninform of progress, to identify areas for improvement and to support\nthe demonstration of accountability to the men’s health field and\nthe community\n• An evaluation framework for each of the Grant Programs (Action\nareas: 1.3, 2.2 and 2.3)\n• Each evaluation framework would include its purpose, scope,\nprogram logic model, key questions to be answered and for each, the\nkey measures, data sources and methods that will be used.", "impact": "High", "effort": "Low", "proof": "Evidence-backed", "beneficiaries": "Regulated entities / policy teams", "source": "strategies/national-men-s-health-strategy-2020-2030_0.pdf (https://www.health.gov.au/sites/default/files/documents/2021/05/national-men-s-health-strategy-2020-2030_0.pdf)", "implementation": [ "Pick one high-volume process or document family.", "Name an owner and baseline current volume, time, cost, and satisfaction.", "Run a 4-8 week pilot with clear before/after metrics.", "Publish lessons and decide whether to scale." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability", "Regulatory capture", "Over-automation of judgement" ] }, { "entity_id": "B-000708", "entity_name": "National Immunisation Committee", "folder_name": "National-Immunisation-Committee", "category": "Regulation & Policy", "scale": "large", "title": "Adaptive regulation program with live feedback loops", "idea": "Create an adaptive regulation model using sandboxes, industry data, risk scoring, and regular rule updates.", "quote": "[pages 33,34,35]\nns.\n• Develop practical and rigorous evaluation This would include:\nframeworks that will enable the monitoring\n• An overarching evaluation framework for the implementation of this\nof key progress in men’s health and in\nStrategy that would guide routine and periodic evaluation enquiry to\ninitiatives relating to this strategy\ninform of progress, to identify areas for improvement and to support\nthe demonstration of accountability to the men’s health field and\nthe community\n• An evaluation framework for each of the Grant Programs (Action\nareas: 1.3, 2.2 and 2.3)\n• Each evaluation framework would include its purpose, scope,\nprogram logic model, key questions to be answered and for each, the\nkey measures, data sources and methods that will be used.", "impact": "Very High", "effort": "High", "proof": "Evidence-backed", "beneficiaries": "Regulated entities / policy teams", "source": "strategies/national-men-s-health-strategy-2020-2030_0.pdf (https://www.health.gov.au/sites/default/files/documents/2021/05/national-men-s-health-strategy-2020-2030_0.pdf)", "implementation": [ "Create a senior responsible owner and cross-functional delivery team.", "Map legislation, data, privacy, procurement, cyber, and workforce constraints.", "Co-design with users and frontline staff before technology selection.", "Stage delivery through pilots, benefits tracking, and public reporting." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability", "Regulatory capture", "Over-automation of judgement" ] }, { "entity_id": "B-000708", "entity_name": "National Immunisation Committee", "folder_name": "National-Immunisation-Committee", "category": "Citizen Participation", "scale": "small", "title": "Consultation feedback summaries with response tracking", "idea": "Summarise consultation submissions by theme and publish what changed in response.", "quote": "[pages 23,24,25,26,27]\numstances specific to the\nto participate in multiple target population group/s and\nengagement activities on the same identify any potential limitations\nor similar issues), as this can result in or constraints to engagement.\nengagement fatigue and be a barrier Mitigate these by fostering a safe\nto establishing sustained, trusted and inclusive environment for all\nrelationships with consumers and consumers.\ncommunities.\n• Investigate any other\nengagement activities that are\nunder way or have been\nundertaken in the community\npreviously to inform engagement\nplanning and avoid over-\nengagement with certain\ncommunities and population\ngroups.\n• Talk to community leaders, local\nstakeholders and consumers\ndirectly (where appropriate), to\ncanvass their views on the policy\nissue/s being considered.", "impact": "High", "effort": "Low", "proof": "Evidence-backed", "beneficiaries": "Citizens / stakeholders / policy teams", "source": "strategies/national-consumer-engagement-strategy-for-health-and-wellbeing.pdf (https://www.health.gov.au/sites/default/files/2025-10/national-consumer-engagement-strategy-for-health-and-wellbeing.pdf)", "implementation": [ "Pick one high-volume process or document family.", "Name an owner and baseline current volume, time, cost, and satisfaction.", "Run a 4-8 week pilot with clear before/after metrics.", "Publish lessons and decide whether to scale." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability", "Digital exclusion", "Low public trust if feedback is not acted on" ] }, { "entity_id": "B-000708", "entity_name": "National Immunisation Committee", "folder_name": "National-Immunisation-Committee", "category": "Citizen Participation", "scale": "large", "title": "Always-on policy participation platform", "idea": "Create a standing participation platform where citizens and stakeholders can propose, vote, and track ideas.", "quote": "[pages 23,24,25,26,27]\numstances specific to the\nto participate in multiple target population group/s and\nengagement activities on the same identify any potential limitations\nor similar issues), as this can result in or constraints to engagement.\nengagement fatigue and be a barrier Mitigate these by fostering a safe\nto establishing sustained, trusted and inclusive environment for all\nrelationships with consumers and consumers.\ncommunities.\n• Investigate any other\nengagement activities that are\nunder way or have been\nundertaken in the community\npreviously to inform engagement\nplanning and avoid over-\nengagement with certain\ncommunities and population\ngroups.\n• Talk to community leaders, local\nstakeholders and consumers\ndirectly (where appropriate), to\ncanvass their views on the policy\nissue/s being considered.", "impact": "Very High", "effort": "High", "proof": "Evidence-backed", "beneficiaries": "Citizens / stakeholders / policy teams", "source": "strategies/national-consumer-engagement-strategy-for-health-and-wellbeing.pdf (https://www.health.gov.au/sites/default/files/2025-10/national-consumer-engagement-strategy-for-health-and-wellbeing.pdf)", "implementation": [ "Create a senior responsible owner and cross-functional delivery team.", "Map legislation, data, privacy, procurement, cyber, and workforce constraints.", "Co-design with users and frontline staff before technology selection.", "Stage delivery through pilots, benefits tracking, and public reporting." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability", "Digital exclusion", "Low public trust if feedback is not acted on" ] }, { "entity_id": "B-000708", "entity_name": "National Immunisation Committee", "folder_name": "National-Immunisation-Committee", "category": "Citizen Services", "scale": "small", "title": "Plain-language service pages and proactive status updates", "idea": "Rewrite high-volume pages and letters into plain language, add status notifications, and measure contact reduction.", "quote": "[pages 42,43,44]\nwomen from\nculturally and linguistically diverse backgrounds and women\nwith disability.\n• Increase the capacity of the workforce, particularly frequently\naccessed health care practitioners such as: GPs, community\npharmacists, Aboriginal Health practitioners and community\nEducate the broader health workforce health organisations, with tools to provide support and links\nabout indicators that a woman or her to services while ensuring safety as a priority.\nchildren may be experiencing family • Consider specific actions to reduce harm and improve\nand/or sexual violence engagement with the health system, including:\n− Provision of trauma informed care\n− Mother and child-only clinic appointments\n− Flexible arrangements for health service access\n| National Women’s Health Strategy 2020-2030 | | 42 |", "impact": "High", "effort": "Low", "proof": "Evidence-backed", "beneficiaries": "Citizens / service users", "source": "strategies/national-women-s-health-strategy-2020-2030_0.pdf (https://www.health.gov.au/sites/default/files/documents/2021/05/national-women-s-health-strategy-2020-2030_0.pdf)", "implementation": [ "Pick one high-volume process or document family.", "Name an owner and baseline current volume, time, cost, and satisfaction.", "Run a 4-8 week pilot with clear before/after metrics.", "Publish lessons and decide whether to scale." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability", "Digital exclusion", "Low public trust if feedback is not acted on" ] }, { "entity_id": "B-000708", "entity_name": "National Immunisation Committee", "folder_name": "National-Immunisation-Committee", "category": "Citizen Services", "scale": "large", "title": "Single front door for life-event based services", "idea": "Bundle services around life events so citizens can complete related steps across agencies in one journey.", "quote": "[pages 42,43,44]\nwomen from\nculturally and linguistically diverse backgrounds and women\nwith disability.\n• Increase the capacity of the workforce, particularly frequently\naccessed health care practitioners such as: GPs, community\npharmacists, Aboriginal Health practitioners and community\nEducate the broader health workforce health organisations, with tools to provide support and links\nabout indicators that a woman or her to services while ensuring safety as a priority.\nchildren may be experiencing family • Consider specific actions to reduce harm and improve\nand/or sexual violence engagement with the health system, including:\n− Provision of trauma informed care\n− Mother and child-only clinic appointments\n− Flexible arrangements for health service access\n| National Women’s Health Strategy 2020-2030 | | 42 |", "impact": "Very High", "effort": "High", "proof": "Evidence-backed", "beneficiaries": "Citizens / service users", "source": "strategies/national-women-s-health-strategy-2020-2030_0.pdf (https://www.health.gov.au/sites/default/files/documents/2021/05/national-women-s-health-strategy-2020-2030_0.pdf)", "implementation": [ "Create a senior responsible owner and cross-functional delivery team.", "Map legislation, data, privacy, procurement, cyber, and workforce constraints.", "Co-design with users and frontline staff before technology selection.", "Stage delivery through pilots, benefits tracking, and public reporting." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability", "Digital exclusion", "Low public trust if feedback is not acted on" ] }, { "entity_id": "B-000708", "entity_name": "National Immunisation Committee", "folder_name": "National-Immunisation-Committee", "category": "Procurement & Delivery", "scale": "small", "title": "Procurement lessons library for repeat purchases", "idea": "Capture reusable procurement clauses, market lessons, supplier performance notes, and common evaluation criteria.", "quote": "Health equity Target: Australians in regional and • B y increasing the amount of healthy years of life for\npeople within these communities, their health will be\nis achieved remote areas will have at least an\non a level that is closer to other Australians by 2030.\nfor priority additional three years of life lived\npopulations in full health by 2030\nTarget: Aboriginal and Torres\nStrait Islander people have at least\nan additional three years of life\nlived in full health by 2030\nUnderpinned by: Investment in • T his means that over the next 10 years, more money\nInvestment preventive health will rise to be will be invested to keep Australians healthy and well.\nin prevention 5% of total health expenditure • Increasing investment to 5% will significantly increase\nis increased across Commonwealth, state and the amount of prevention activities that can implemented", "impact": "High", "effort": "Low", "proof": "Evidence-backed", "beneficiaries": "Delivery teams / suppliers", "source": "strategies/national-preventive-health-strategy-2021-2030-national-preventive-health-strateg.pdf (https://www.health.gov.au/sites/default/files/documents/2021/12/national-preventive-health-strategy-2021-2030-national-preventive-health-strategy-2021-2030-summary.pdf)", "implementation": [ "Pick one high-volume process or document family.", "Name an owner and baseline current volume, time, cost, and satisfaction.", "Run a 4-8 week pilot with clear before/after metrics.", "Publish lessons and decide whether to scale." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability" ] }, { "entity_id": "B-000708", "entity_name": "National Immunisation Committee", "folder_name": "National-Immunisation-Committee", "category": "Procurement & Delivery", "scale": "large", "title": "Portfolio delivery office for major investments", "idea": "Stand up a portfolio delivery office that tracks benefits, risks, dependencies, procurement, and delivery confidence.", "quote": "Health equity Target: Australians in regional and • B y increasing the amount of healthy years of life for\npeople within these communities, their health will be\nis achieved remote areas will have at least an\non a level that is closer to other Australians by 2030.\nfor priority additional three years of life lived\npopulations in full health by 2030\nTarget: Aboriginal and Torres\nStrait Islander people have at least\nan additional three years of life\nlived in full health by 2030\nUnderpinned by: Investment in • T his means that over the next 10 years, more money\nInvestment preventive health will rise to be will be invested to keep Australians healthy and well.\nin prevention 5% of total health expenditure • Increasing investment to 5% will significantly increase\nis increased across Commonwealth, state and the amount of prevention activities that can implemented", "impact": "Very High", "effort": "High", "proof": "Evidence-backed", "beneficiaries": "Delivery teams / suppliers", "source": "strategies/national-preventive-health-strategy-2021-2030-national-preventive-health-strateg.pdf (https://www.health.gov.au/sites/default/files/documents/2021/12/national-preventive-health-strategy-2021-2030-national-preventive-health-strategy-2021-2030-summary.pdf)", "implementation": [ "Create a senior responsible owner and cross-functional delivery team.", "Map legislation, data, privacy, procurement, cyber, and workforce constraints.", "Co-design with users and frontline staff before technology selection.", "Stage delivery through pilots, benefits tracking, and public reporting." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability" ] } ], "legislation_administered": [], "artifacts": [ { "category": "strategies", "year": "2024", "url": "https://www.digital.gov.au/sites/default/files/documents/2024-08/Standard%20for%20AI%20transparency%20statements%20v1.1.pdf", "file": "strategies/Standard-20for-20AI-20transparency-20statements-20v1.1.pdf", "bytes": 289017, "link_text": "Standard for AI transparency statements" }, { "category": "strategies", "year": "2021", "url": "https://www.health.gov.au/sites/default/files/documents/2021/12/national-preventive-health-strategy-2021-2030_1.pdf", "file": "strategies/national-preventive-health-strategy-2021-2030_1.pdf", "bytes": 9599506, "link_text": "National Preventive Health Strategy 2021–2030 [PDF - 10 MB] - 95 pages" }, { "category": "strategies", "year": "2021", "url": "https://www.health.gov.au/sites/default/files/documents/2021/12/national-preventive-health-strategy-2021-2030-national-preventive-health-strategy-2021-2030-summary.pdf", "file": "strategies/national-preventive-health-strategy-2021-2030-national-preventive-health-strateg.pdf", "bytes": 941481, "link_text": "National Preventive Health Strategy 2021–2030 [PDF - 920 KB] - 2 pages" }, { "category": "strategies", "year": "2021", "url": "https://www.health.gov.au/sites/default/files/documents/2021/05/national-men-s-health-strategy-2020-2030_0.pdf", "file": "strategies/national-men-s-health-strategy-2020-2030_0.pdf", "bytes": 2299972, "link_text": "National Men's Health Strategy 2020–2030 [PDF - 3 MB] - 42 pages" }, { "category": "strategies", "year": "2021", "url": "https://www.health.gov.au/sites/default/files/documents/2021/05/national-women-s-health-strategy-2020-2030_0.pdf", "file": "strategies/national-women-s-health-strategy-2020-2030_0.pdf", "bytes": 2132351, "link_text": "National Women's Health Strategy 2020–2030 [PDF - 3 MB] - 59 pages" }, { "category": "strategies", "year": "2021", "url": "https://www.health.gov.au/sites/default/files/documents/2021/04/national-action-plan-for-the-health-of-children-and-young-people-2020-2030-national-action-plan-for-the-health-of-children-and-young-people-2020-2030.pdf", "file": "strategies/national-action-plan-for-the-health-of-children-and-young-people-2020-2030-natio.pdf", "bytes": 1832162, "link_text": "National Action Plan for the Health of Children and Young People 2020–2030 [PDF - 2 MB] - 52 pages" }, { "category": "strategies", "year": "2026", "url": "https://www.health.gov.au/sites/default/files/2026-03/national-strategic-framework-for-chronic-conditions_0.pdf", "file": "strategies/national-strategic-framework-for-chronic-conditions_0.pdf", "bytes": 1949898, "link_text": "National Strategic Framework for Chronic Conditions [PDF - 2 MB]" }, { "category": "strategies", "year": "2022", "url": "https://www.health.gov.au/sites/default/files/documents/2022/03/national-obesity-strategy-2022-2032_0.pdf", "file": "strategies/national-obesity-strategy-2022-2032_0.pdf", "bytes": 1819003, "link_text": "National Obesity Strategy 2022–2032 [PDF - 2 MB] - 87 pages" }, { "category": "strategies", "year": "2023", "url": "https://www.health.gov.au/sites/default/files/2023-05/national-tobacco-strategy-2023-2030.pdf", "file": "strategies/national-tobacco-strategy-2023-2030.pdf", "bytes": 1088338, "link_text": "National Tobacco Strategy 2023–2030 [PDF - 2 MB] - 46 pages" }, { "category": "strategies", "year": "2020", "url": "https://www.health.gov.au/sites/default/files/documents/2020/11/national-alcohol-strategy-2019-2028.pdf", "file": "strategies/national-alcohol-strategy-2019-2028.pdf", "bytes": 596117, "link_text": "National Alcohol Strategy 2019–2028 [PDF - 583 KB] - 44 pages" }, { "category": "strategies", "year": "2025", "url": "https://www.health.gov.au/sites/default/files/2025-10/national-consumer-engagement-strategy-for-health-and-wellbeing.pdf", "file": "strategies/national-consumer-engagement-strategy-for-health-and-wellbeing.pdf", "bytes": 2867878, "link_text": "National Consumer Engagement Strategy for Health and Wellbeing [PDF - 3 MB]" }, { "category": "other-pdfs", "year": null, "url": "https://www.health.gov.au/sites/default/files/nip-vaccine-listing.pdf", "file": "other-pdfs/nip-vaccine-listing.pdf", "bytes": 86866, "link_text": "National Immunisation Program (NIP) vaccine listing process [PDF - 85 KB] - 1 page" } ], "_meta": { "snapshot_built_at": "2026-05-13T11:02:56+00:00", "strategy_brief_meta": { "model": "nova-micro", "folder": "National-Immunisation-Committee", "annual_report": { "file": null, "url": "", "year": null }, "corporate_plan": { "file": "strategies\\national-tobacco-strategy-2023-2030.txt", "url": "https://www.health.gov.au/sites/default/files/2023-05/national-tobacco-strategy-2023-2030.pdf", "year": "national-tobacco-strategy-2023-2030" }, "usage": { "input_tokens": 14269, "output_tokens": 920, "total_tokens": 15189, "model": "nova-micro" }, "cost_usd": 0.000628215, "elapsed_seconds": 19.28, "generated_at": "2026-05-13T05:18:06+00:00" }, "ideas_manifest": { "entity_id": "B-000708", "entity_name": "National Immunisation Committee", "folder_name": "National-Immunisation-Committee", "generated_at": "2026-05-09T23:06:02.125518+00:00", "idea_count": 12, "markdown": "ideas/National-Immunisation-Committee_ideas.md", "jsonl": "ideas/ideas.jsonl", "inputs": [ "National-Immunisation-Committee_strategy-overview.md", "strategy-evidence.json", "global-intelligence/source-manifest.json" ] }, "global_intel_meta": null } }